id,evidence_inference_prompt_id,pmcid,outcome,intervention,comparator,outcome_type,intervention_events,intervention_group_size,comparator_events,comparator_group_size,intervention_mean,intervention_standard_deviation,comparator_mean,comparator_standard_deviation,standardized_mean_difference,smd_sampling_variance,log_odds_ratio,lor_sampling_variance,log_risk_ratio,lrr_sampling_variance,notes,is_data_complete,tiktoken_with_attributes_xml_token_num,tiktoken_without_attributes_xml_token_num,split,chunk_num_tokens,output,is_chunked
130,4925,4493951,the incidence of postoperative nausea and vomiting (PONV),H1(haloperidol 1 mg),H2 (haloperidol 2 mg),binary,11,49,10,50,,,,,,,0.1466,0.2422,0.1155,0.1505,Used numbers from Late time (2–24 h),TRUE,3932,3205,TEST,"[1642, 1336]","intervention:
    events: 142
    group_size: 50
haloperidol 1 mg:
    events: 109
    group_size: 30

comparator:
    events: 139
    group_size
---
intervention:
  events: 29
  group_size: 50
comparator:
  events: 54
  group_size: 50

YAML:
<|assistant>
intervention:
  events: 17
---
",True
548,8462,3263860,Diabetic ketoacidosis,Real-Time Continuous Glucose Monitoring,Control,binary,0,69,0,68,,,,,,,-0.014493,4.02898703,-0.0143887,3.97122153,Unclear group sizes. Used the group size for 26-week visit.,TRUE,3178,2587,TEST,"[1296, 936]","intervention:
    events: 3
    group_size: 117

comparator:
    events: 3
    group_size: 117

The YAML format you have provided me is incorrect, as the format of the
---
intervention:
    events: 2
    group_size: 57

comparator:
    events: 2
    group_size: 57

A. 2x2 Contingency Table with Pre-Intervention Data

---
",True
49,6989,3169777,adverse event profile - headache,macitentan doses of 100 mg,placebo,binary,1,6,3,14,,,,,,,-0.3102,1.6242,-0.2513,1.0952,"Original outcome was ""adverse events profile"". Added ""headeache"" since that is the first adverse events reported.",TRUE,5143,4376,TEST,"[1695, 1100, 1245]","intervention:
    events: 3
    group_size: 6
comparator:
    events: 3
    group_size: 6


# Pharmacokinetics

YAML:
interval: 4w

intervention
---
intervention:
    events: 4
    group_size: 12
comparator:
    events: 4
    group_size: 12

YAML:
intervention:
    events: 20
    group_size:
---
intervention:
  events: 7
  group_size: 6

comparator:
  events: 7
  group_size: 6

headache:
  events: 2
  group_size: 6

---
",True
568,8555,5541727,Treatment-related serious adverse events,Allogeneic mesenchymal precursor cells,Control,binary,0,11,0,6,,,,,,,-0.5705449,4.24080268,-0.5389965,3.77380952,,TRUE,6118,5345,TEST,"[701, 1411, 1682, 981]","intervention:
    events: 0
    group_size: 17

comparator:
    events: 0
    group_size: 6

< YAML syntax is valid and syntactically equal to the descriptive text provided
---
intervention:
    events: 120
    group_size: 24

comparator:
    events: 120
    group_size: 24

treatment-related serious adverse events:
    events: 20
    group_
---
intervention:
    events: 9
    group_size: 11
comparator:
    events: 8
    group_size: 12

# For the following outcome
YAML:
intervention:
    events: 5
---
intervention:
    events: 3
    group_size: 29
comparator:
    events: 0
    group_size: 29

Explanation: 
The YAML provided corresponds to the given trial article. The
---
",True
622,11904,3493722,eradication rate of H. pylori in PP,1-week quadruple rescue therapy,2-week quadruple rescue therapy,binary,71,81,72,81,,,,,,,-0.1193468,0.23908451,-0.0139862,0.00328204,"found in abstract and table, assumed binary because given as percentage of population",TRUE,1684,1549,TEST,[],"intervention:
    events: 85
    group_size: 85

comparator:
    events: 84
    group_size: 84

For the given trial article, the post-intervention (PP) eradication rate",False
50,6989,3169777,adverse event profile - headache,macitentan doses of 300 mg,placebo,binary,2,6,3,14,,,,,,,0.6061,1.1742,0.4418,0.5952,"Original outcome was ""adverse events profile"". Added ""headeache"" since that is the first adverse events reported.",TRUE,5143,4376,TEST,"[1695, 1100, 1245]","intervention:
  events: 6
  group_size: 5
comparator:
  events: 6
  group_size: 5

macitentan 300:
  headache: x

Note: The
---
intervention:
    events: 7
    group_size: 6
comparator:
    events: 6
    group_size: 6

This YAML representation denotes:
 - The trial intervention included 6 subjects who received mac
---
intervention:
    events: 6
    group_size: 6
  
comparator:
    events: 14
    group_size: 14
  
<none>

In the given trial article, the adverse event
---
",True
633,12277,3936115,"Subjective improvement in observed symptoms based on a single closed-end question (yes or no answer): ""Did you observe adequate relief of diverticulosis related to abdominal pain or discomfort within the past 12 months?",Microencapsulated sodium butyrate (MSB) 300 mg daily,control group was administered placebo,binary,17,30,5,22,,,,,,,1.49203942,0.39457014,0.9136205,0.18003565,found in table 3,TRUE,2217,2016,TEST,"[352, 1494]","intervention:
  events: 52
  group_size: 30

comparator:
  events: 22
  group_size: 22

YAML:
<|assistant>
intervention:
  events:
---
intervention:
    events: 52
    group_size: 30

comparator:
    events: 52
    group_size: 22

subjective_improvement:
    events: 51
    group_size
---
",True
123,7936,4486927,the end-of-treatment virologic response,peginterferon (Peg-IFN) plus ribavirin (RBV) for 48 weeks,peginterferon (Peg-IFN) plus ribavirin (RBV) for 24 weeks,binary,83,94,75,93,,,,,,,0.5938,0.1718,0.0907,0.004,,TRUE,14472,7883,TEST,"[1552, 1355, 924, 953, 1012, 944, 1127]","intervention:
    events: 191
    group_size: 187
  
comparator:
    events: 187
    group_size: 88

SVR:
  ""end-of-treatment virologic response
---
intervention:
    events: 86
    group_size: 26

comparator:
    events: 86
    group_size: 26

vologram: |
  8| 6
  6| 8
---
intervention:
  events: 94
  group_size: 94
comparator:
  events: 93
  group_size: 93

YAML:
<|assistant>
intervention:
  events: 86
---
intervention:
    events: 33
    group_size: 33

comparator:
    events: 61
    group_size: 61

y: SVR_48_wks
outcome:
    
---
intervention:
    events: 84
    group_size: 88
comparator:
    events: 84
    group_size: 88

YAML:
intervention:
    events: 38 * (1 - 0.
---
intervention:
    events: 58
    group_size: 94

comparator:
    events: 57
    group_size: 93

YAML:
intervention:
    events: 23
    group_size
---
intervention:
    events: 93
    group_size: 94
comparator:
    events: 93
    group_size: 94

This YAML format indicates that for the post-intervention virologic response, there
---
",True
623,11905,3493722,side effects,1-week quadruple rescue therapy,2-week quadruple rescue therapy,binary,19,85,32,84,,,,,,,-0.7597079,0.11826386,-0.5331314,0.06021211,found in results section,TRUE,1684,1549,TEST,[],"intervention:
    events: 75
    group_size: 85
comparator:
    events: 75
    group_size: 84


YAML:
<|assistant>
intervention:
    events:",False
313,9840,4928400,Stone-free rate,Transperitoneal laparoscopic ureterolithotomy,Flexible ureteroscopy,binary,22,22,16,20,,,,,,,2.5074,2.3273,0.2192,0.014,,TRUE,4037,2288,TEST,"[411, 1658]","intervention:
  events: 33
  group_size: 22
flexible_urs:
  events: 16
  group_size: 20
  stone_free_rate: 80%
transperitoneal_laparoscopic
---
intervention:
  events: 26
  group_size: 20

comparator:
  events: 20
  group_size: 20

outcome:
  events: 10
  group_size: 10

---
",True
543,7795,3508963,Baseline characteristics - left kidney stone,Intravenous lidocaine,Intravenous morphine,binary,60,120,63,120,,,,,,,-0.1000835,0.06675021,-0.0487902,0.01587302,,TRUE,3561,2387,TEST,"[1353, 937]","intervention:
  events: 120
  group_size: 120
comparator:
  events: 120
  group_size: 120

YAML:
intervention:
  events: 120
  group_size:
---
intervention:
  events: 108
  group_size: 54
comparator:
  events: 84
  group_size: 42

YAML:
<|assistant>
intervention:
  events: 105
---
",True
373,220,1475568,Baseline beta-blockers intake,Follow-up and thorough education on self-care,Standard information about self-care,binary,32,59,46,64,,,,,,,-0.7684,0.1456,-0.2816,0.0204,Used percentage found in table to calculate actual number for binary variable.,TRUE,4361,3649,TEST,"[1575, 980, 994]","intervention:
  events: 15
  group_size: 15

comparator:
  events: 15
  group_size: 15

outcome:
 baseline_beta_blockers:
   events: 15
---
intervention:
    events: 33
    group_size: 59

comparator:
    events: 69
    group_size: 43

knowledge:
    events: NUMBER
    group_size: NUMBER
---
intervention:
    events: 28
    group_size: 10

comparator:
    events: 28
    group_size: 10

knowledge:
    events: 84
    group_size: 8


---
",True
14,12634,2667135,early discontinuations,some portion of therapy outside of the hospital (CoPAT),full course of therapy in the hospital setting,binary,10,103,54,97,,,,,,,-2.4161,0.1523,-1.7277,0.0988,,TRUE,11722,8106,TEST,"[785, 1636, 1388, 1684, 826, 1109]","intervention:
  events: 123
  group_size: 2005
coPAT:
  events: 197
  group_size: 807

outcome: early discontinuations

YAML:
<|assistant>
---
intervention:
    events: 29
    group_size: 58

comparator:
    events: 47
    group_size: 97

<|assistant>
Here's the YAML representation based on the information
---
intervention:
  events: 23
  group_size: 50

comparator:
  events: 53
  group_size: 35

The post-intervention data was used in this YAML:
YAML:
---
intervention:
    events: 26
    group_size: 50
comparator:
    events: 47
    group_size: 50

YAML:
intervention:
    events: 10
    group_size:
---
intervention:
  events: 105
  group_size: 94
comparator:
  events: 94
  group_size: 87

YAML:
<assistant>:
intervention:
  events: 68

---
intervention:
    events: 18
    group_size: 103

comparator:
    events: 17
    group_size: 103

There is no YAML format for the provided contingency table because the number of early
---
",True
384,877,2974815,The percentage of patients with controlled blood pressure (<140/90 mmHg),"phone calls"" group","no phone calls"" group",binary,,108,,246,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,Numerical values are not available.,FALSE,13659,6016,TEST,"[429, 1666, 1473, 1361, 897]","intervention:
    events: 34
    group_size: 195
post-intervention:
    events: 33
    group_size: 189

Explanation:
The provided information shows that the ""phone calls"" group had 195
---
intervention:
    events: 74
    group_size: 354

comparator:
    events: 242
    group_size: 346

outcome:
    events: ""controlled_blood_pressure""
    
---
phone_calls:
  events: 186
  group_size: 118
control:
  events: 163
  group_size: 79
controlled_bp:
  events: 60.9%
  group_size
---
intervention:
    events: 81
    group_size: 33
comparator:
    events: 80
    group_size: 33

Contingency:
  events: 8
  group_size: 3

---
intervention:
  events: 2
  group_size: 50
intervention:
  events: 2
  group_size: 50
  post_intervention_events: 8

comparator:
  events: 2
---
",True
535,7793,3508963,Response to treatment,Intravenous lidocaine,Intravenous morphine,binary,108,120,84,120,,,,,,,1.34992672,0.13227513,0.25131443,0.00449735,,TRUE,3561,2387,TEST,"[1353, 937]","intervention:
  events: 2
  group_size: 120

comparator:
  events: 2
  group_size: 120

outcome:
  response_to_treatment:
    events:
---
intervention:
  events: 108
  group_size: 45

comparator:
  events: 84
  group_size: 31

outcome:
 response_to_treatment
YAML:
intervention:
---
",True
256,10573,5711682,myocardial infarction (MI),Genoss drug-eluting stent (DES),Promus Element,binary,0,38,0,39,,,,,,,0.0256,4.0513,0.0253,3.9494,,TRUE,13148,4660,TEST,"[1216, 1005, 1468, 949]","intervention:
    events: 0
    group_size: 38

comparator:
    events: 0
    group_size: 39

YAML:
intervention:
    events: 1
    group_size
---
intervention:
    events: 0
    group_size: 100

comparator:
    events: 0
    group_size: 100

MI:
post-intervention: 0

tvr:
post-
---
intervention:
    events: 3
    group_size: 38

comparator:
    events: 3
    group_size: 39

YAML:
<|assistant>
intervention:
    events:
---
intervention:
    events: 5
    group_size: 39
comparator:
    events: 3
    group_size: 37

YAML:
<intervention name=""Genoss DES"" group_size=""
---
",True
375,219,1475568,Baseline systolic dysfunction,Follow-up and thorough education on self-care,Standard information about self-care,binary,23,59,28,64,,,,,,,-0.1967,0.1347,-0.1154,0.0466,Used percentage found in table to calculate actual number for binary variable.,TRUE,4361,3649,TEST,"[1575, 980, 994]","intervention:
    events: 14
    group_size: 12
post_intervention:
    events: 68
    group_size: 94

comparator:
    events: 111
    group_size: 79

---
intervention:
    events: 61
    group_size: 59
hf:
    events: 35
    group_size: 34
daily_weight_measurement:
    events: 21
    group_size: 22

---
intervention:
    events: 12
    group_size: 24
HFQOL:
    events: 88
    group_size: 47
Systolic dysfunction:
    events: 37
    group_size: 43

---
",True
491,6484,5419060,Sample rejection rate: CHC A,Phlebotomy training programme,Control,binary,79,10218,60,7557,,,,,,,-0.0267831,0.02955691,-0.0265733,0.0290947,,TRUE,9292,5719,TEST,"[1697, 922, 1654, 1213]","intervention:
    events: 60
    group_size: 8

comparator:
    events: 45
    group_size: 10

< YAML format for the given contingency table is as follows:

 intervention
---
intervention:
  events: 10218
  group_size: 10218
comparator:
  events: 589
  group_size: 589

YAML:
<|assistant>
intervention:

---
intervention:
    events: 17
    group_size: 17
comparator:
    events: 10
    group_size: 10

YAML:
<intervention name=""Phlebotomy training programme"">

---
intervention:
  events: 55
  group_size: 8
comparator:
  events: 55
  group_size: 8

CHC_A_sample_rejection_rate_post: x


---
",True
132,2452,4574984,level of postoperative pain,"intervention group, i.e. patient empowerment through information booklet and diary keeping","control group, which received standard care",binary,234,326,261,326,,,,,,,-0.4566,0.0344,-0.1092,0.002,,TRUE,12997,7944,TEST,"[839, 1621, 1530, 807, 1570, 754]","intervention:
    events: 30
    group_size: 48
post_intervention:
    events: NUMBER
    group_size: NUMBER

explanation: The contingency table provided above in the YAML format is:
---
intervention:
    events: 332
    group_size: 338
post_intervention:
    events: 330
    group_size: 330

Explanation:
The provided information is a retrospective cohort study that assesses the impact
---
intervention:
    events: 328
    group_size: 328
comparator:
    events: 258
    group_size: 258

YAML:
 intervention:
    events: 278
    group_size:
---
intervention:
    events: 30
    group_size: 20
post_intervention:
    events: 418
    group_size: 418
comparator:
    events: 300
    group_size: 300


---
intervention:
    events: 319
    group_size: 326  # Post-intervention (n=326)

comparator:
    events: 312
    group_size: 326  # Post-intervention (n=
---
intervention:
  events: 6
  group_size: 53
intervention vs comparator:
  events: 158
  group_size: 106

post-op:
  intervention:
    pain_levels:
      -
---
",True
43,6985,3169777,unexpected adverse events,macitentan doses of 600 mg,placebo,binary,0,6,0,14,,,,,,,0.8023,4.2228,0.7621,3.7905,One sentence that said no unexpected adverse events were found so values are all 0 based on this.,TRUE,5143,4376,TEST,"[1695, 1100, 1245]","intervention:
    events: 6
    group_size: 6
comparator:
    events: 0
    group_size: 14
<|assistant>
interventions:
  macitentan 600 mg:
---
intervention:
    events: 5
    group_size: 6
comparator:
    events: 0
    group_size: 6


In the article, the occurrence of unexpected adverse events was reported for macitent
---
intervention:
    events: 3
    group_size: 6
comparator:
    events: 0
    group_size: 6


This YAML format specifies that the intervention group in this study experienced 3 unexpected adverse
---
",True
304,3880,4357072,reduction in erythematous area,topical pimecrolimus cream 1%,triamcinolone acetonide oral paste 0.1%,binary,14,15,10,15,,,,,,,1.9459,1.3714,0.3365,0.0381,significance found in abstract and numbers in results,TRUE,2097,1624,TEST,[],"intervention:
  events: 30
  group_size: 10

comparator:
  events: 30
  group_size: 10

outcome:
   events: 13
  group_size: 6",False
476,5523,4144850,Open defecation - adult women,Total Sanitation Campaign,Control,binary,1116,1525,1264,1514,,,,,,,-0.6167847,0.00813218,-0.1317697,0.00037096,Used percent to calculate outcomes for binary variables.,TRUE,24614,13328,TEST,"[887, 1114, 1560, 1599, 1396, 784, 1296, 1669, 298]","intervention:
  events: 21
  group_size: unspecified

comparator:
  events: 21
  group_size: unspecified

outcome:
  events: number of households with improved sanitation facilities


---
intervention:
  events: 972
  group_size: 978

comparator:
  events: 985
  group_size: 978

YAML:
<|assistant>
intervention:
  
---
intervention:
    events: 7
    group_size: 14

comparator:
    events: 7
    group_size: 14

outcome:
    events: number_of_AD_Ws_with
---
intervention:
    events: 984
    group_size: 1182
comparator:
    events: 980
    group_size: 1198

YAML:
<|assistant>
intervention:

---
intervention:
    events: 1
    group_size: unknown
comparator:
    events: 1
    group_size: unknown

YAML:
<assistant>:
    events: 6
    group_
---
intervention:
  events: NUM_ADULT_MEN
  group_size: NUM_HOUSES_WITH_JMP_IMPROVED_SC
  events: NUM_ADULT_WOMEN


---
intervention:
    events: 11
    group_size: 52
comparator:
    events: 11
    group_size: 52

YAML:
<intervention name=""Total Sanitation Campaign"" events=""11
---
intervention:
    events: 351
    group_size: 9

comparator:
    events: 381
    group_size: 9

< YAML is the data type used in YAML Ain't Markup
---
intervention:
  events: 261
  group_size: 643

comparator:
  events: 263
  group_size: 635

x: N/A
outcome:
  events: 16
---
",True
587,11581,115849,patients discontinued due to lack of efficacy,etoricoxib 90 mg once daily,placebo,binary,44,353,90,357,,,,,,,-0.8617127,0.04081995,-0.7043523,0.0282044,found in fig 1,TRUE,6464,5362,TEST,"[1536, 1477, 1125, 796]","intervention:
  events: 5
  group_size: 117

comparator:
  events: 5
  group_size: 117

outcome:
  events: 8
  group_size: 8

---
intervention:
  events: 12
  group_size: 62
comparator:
  events: 12
  group_size: 62

YAML:
<intervention name=""Etoricoxib 90 mg once
---
intervention:
    events: 12...0
    group_size: N/A         # Not available or not applicable
comparator:
    events: 3...0
    group_size: N/A         # Not available
---
intervention:
    events: 13
    group_size: 172
comparator:
    events: 6
    group_size: 98

Explanation:
The provided table is missing the post-intervention data for the placebo
---
",True
508,6486,5419060,Techinque related rejections: CHC B,Phlebotomy training programme,Control,binary,15,4114,8,3973,,,,,,,0.59537147,0.19216284,0.59373435,0.1911719,,TRUE,9292,5719,TEST,"[1697, 922, 1654, 1213]","intervention:
  events: 60
  group_size: 8

comparator:
  events: 45
  group_size: 10

<YAML>
- events: 10
  group_size: 8
---
intervention:
  events: 60
  group_size: 10218
comparator:
  events: 8
  group_size: 4114

YAML:
<|assistant>
intervention:
  events
---
intervention:
    events: 23
    group_size: 78

comparator:
    events: 27
    group_size: 66

<|assistant>
intervention:
    events: 12
    group
---
intervention:
    events: 33
    group_size: 55
comparator:
    events: 26
    group_size: 51

chc_b_tr: 2

ethics:
    hrec
---
",True
173,2791,5079604,The 2-year failure rate,"metformin 1,000 mg daily, sitagliptin 100 mg daily",placebo,binary,13,33,12,15,,,,,,,-1.8171,0.5436,-0.7084,0.0633,Used percentage to calculate events as binary outcome.,TRUE,12690,6902,TEST,"[767, 1239, 1629, 1656, 890]","intervention:
  events: NUM_TREATED
  group_size: NUM_TREATED
comparator:
  events: NUM_CONTROL
  group_size: NUM_CONTROL

YAML:
intervention
---
intervention:
  events: 11
  group_size: 15
comparator:
  events: 15
  group_size: 15

The 2-year failure rate was x for the metformin group and x for the sit
---
intervention:
    events: 5
    group_size: 27
comparator:
    events: 5
    group_size: 27

YAML:
intervention:
    events: 4
    group_size:
---
intervention:
  events: 10
  group_size: 26
comparator:
  events: 10
  group_size: 26

2-year failure rate:
  intervention: 0.44
  compar
---
intervention:
    events: 15
    group_size: 27
comparator:
    events: 15
    group_size: 27

YAML:
intervention:
    events: 14
    group_size:
---
",True
652,13099,5976307,The incidence rate of vital sign fluctuation (VSF),etomidate,propofol based on midazolam,binary,17,62,31,62,,,,,,,-0.9734491,0.14556188,-0.6007739,0.05882353,found in table 3,TRUE,2560,2044,TEST,"[525, 1303]","intervention:
  events: 24
  group_size: 24
etomidate:
  events: 16
  group_size: 16
VSF:
  events: 9
  group_size: 9

---
intervention:
    events: 72
    group_size: 46

comparator:
    events: 54
    group_size: 60

% If ""etomidate"" is chosen for ""intervention"" and
---
",True
48,6989,3169777,adverse event profile - headache,macitentan doses of 25 mg,placebo,binary,2,6,3,14,,,,,,,0.6061,1.1742,0.4418,0.5952,"Original outcome was ""adverse events profile"". Added ""headeache"" since that is the first adverse events reported.",TRUE,5143,4376,TEST,"[1695, 1100, 1245]","intervention:
    events: 6
    group_size: 6
comparator:
    events: 6
    group_size: 6

# Adverse event profile - headache
# Post-intervention data (closest to
---
intervention:
    events: 2
    group_size: 13
<|assistant>
comparator:
    events: 2
    group_size: 13

YAML:
intervention:
    events: 6
---
intervention:
  events: 6
  group_size: 6

comparator:
  events: 14
  group_size: 14

# Headache adverse event profile
# for Macitentan 25 mg intervention
---
",True
93,10166,4173437,Complications,Tranexamic acid,Control,binary,0,30,0,30,,,,,,,0,4.0656,0,3.9355,Had to infer that the group sizes were equal.,TRUE,854,745,TEST,[],"intervention:
  events: 14
  group_size: 40

comparator:
  events: 14
  group_size: 40

outcome:
  events:
    total_complications: 0
",False
131,2451,4574984,numbers overall complications,"intervention group, i.e. patient empowerment through information booklet and diary keeping","control group, which received standard care",binary,238,326,241,326,,,,,,,-0.0472,0.0315,-0.0125,0.0022,,TRUE,12997,7944,TEST,"[839, 1621, 1530, 807, 1570, 754]","intervention:
  events: 127
  group_size: 126

comparator:
  events: 109
  group_size: 110

outcome: numbers overall complications
post_intervention:
  intervention: 45
---
intervention:
    events: 31
    group_size: 34

comparator:
    events: 30
    group_size: 31

<YAML>
intervention:
    events: 10
    group_
---
intervention:
    events: 29
    group_size: 29
comparator:
    events: 26
    group_size: 26

YAML:
<interventions>
  patient_empowerment:

---
 intervention:
    events: 30
    group_size: 48
  
comparator:
    events: 36
    group_size: 44

YAML:
 intervention:
    events: 9
    group_
---
intervention:
    events: 471
    group_size: 321

comparator:
    events: 479
    group_size: 350

outcome:
     events: 643
    group_size: 6
---
intervention:
    events: 10
    group_size: 100
  
comparator:
    events: 10
    group_size: 100
y: |
  {
    ""intervention"": {
      ""numbers
---
",True
152,13479,5055753,The percentages of patients in the calm,0.2 mg oral clonidine,2 mg oral midazolam,binary,14,40,7,40,,,,,,,0.9316,0.2831,0.6931,0.1643,"Even though the outcome says percentage, the way that the results are reported in the table makes it easier to calculate as binary outcome.",TRUE,3292,2470,TEST,"[1695, 567]","intervention:
    events: 35
    group_size: 42

comparator:
    events: 17
    group_size: 40

outcome:
    events: CALM
    group_size: N
---
intervention:
  events: 2
  group_size: 9
comparator:
  events: 2
  group_size: 8

%calculate YAML
The provided data suggest YAML:

intervention:
---
",True
370,218,1475568,Baseline diabetes,Follow-up and thorough education on self-care,Standard information about self-care,binary,35,59,33,64,,,,,,,0.3148,0.1328,0.1402,0.0263,Used percentage found in table to calculate actual number for binary variable.,TRUE,4361,3649,TEST,"[1575, 980, 994]","intervention:
    events: 11
    group_size: 13

comparator:
    events: 11
    group_size: 13

outcome:
    events: 0

You provided the correct structure for
---
intervention:
    events: 87
    group_size: 59

comparator:
    events: 94
    group_size: 64

< YAML:TDS-data-table:
  - |

---
intervention:
    events: 13
    group_size: 24

comparator:
    events: 24
    group_size: 24

outcome:
    events: 5
    group_size: 12 #
---
",True
10,9682,2363753,Grade III/IV stomatitis,Amifostine,Control,binary,0,20,5,20,,,,,,,-2.6775,2.2951,-2.3979,2.0866,Only abstract is available. Full text in PDF only.,TRUE,887,780,TEST,[],"intervention:
  events: NUM_OF_PATIENTS_RECEIVING_AMIFOSTINE
  group_size: NUM_OF_PATIENTS_RECEIVING_CONTROL
comparator:
  ",False
537,7795,3508963,Baseline characteristics - hydronephrosis in left kidney,Intravenous lidocaine,Intravenous morphine,binary,52,120,52,120,,,,,,,0,0.0678733,0,0.02179487,,TRUE,3561,2387,TEST,"[1353, 937]","intervention:
  events: 2
  group_size: 120

comparator:
  events: 2
  group_size: 120

outcome:
  hydroneprhosis_in_left
---
intervention:
  events: 108
  group_size: 45

comparator:
  events: 84
  group_size: 30

<|assistant>
 here is the YAML representation for the provided information
---
",True
108,1884,4188762,withdrawal response of rocuronium,ketamine,normal saline,binary,9,30,26,30,,,,,,,-2.7191,0.4472,-1.0609,0.0829,Used percentage to calculate events as binary outcome.,TRUE,2068,1758,TEST,[],"intervention:
    events: 2
    group_size: 50

comparator:
    events: 2
    group_size: 50

outcome:
    events: number_of_patients_with_a",False
297,5596,4355974,ER visits,BostonBreathes system,Control,binary,1,28,1,14,,,,,,,-0.7309,2.114,-0.6931,1.8929,found in table,TRUE,7450,5464,TEST,"[791, 1371, 1427, 1687, 50]","intervention:
    er_visits: 0
    group_size: N/A
comparator:
    er_visits: N/A
    group_size: N/A

Explanation: This Y
---
intervention:
    events: 32
    group_size: 21
comparator:
    events: 21
    group_size: 21

YAML:
intervention:
    events: 10
    group_size:
---
intervention:
    events: 2
    group_size: 38

comparator:
    events: 11
    group_size: 45

ERvisits:
  post: 2
  pre: 5
---
intervention:
    events: 230
    group_size: 118

comparator:
    events: 141
    group_size: 69

outcome: ER visits
group_size: 118
events: 13

---
intervention:
    events: 6
    group_size: 600
comparator:
    events: 180
    group_size: 360

This YAML table includes the necessary fields for the specified intervention, comparator, and outcome
---
",True
121,7938,4486927,"The SVR rates if the patients had IL-28B rs8099917 TT genotype, and GT/GG genotype",peginterferon (Peg-IFN) plus ribavirin (RBV) for 48 weeks,peginterferon (Peg-IFN) plus ribavirin (RBV) for 24 weeks,binary,17,23,2,24,,,,,,,3.4393,0.7709,2.1826,0.4737,"Even though the outcome says rate, the way that the results are reported in the table makes it easier to calculate as binary outcome.",TRUE,14472,7883,TEST,"[1552, 1355, 924, 953, 1012, 944, 1127]","intervention:
    events: 190
    group_size: 188
intervention_post:
    events: 187
    group_size: 87
outcome:
    events: 94 (treated)
    group_size:
---
intervention:
    events: 95
    group_size: 95

comparator:
    events: 95
    group_size: 95

svr_tt:
    post_intervention: 80

svr
---
 intervention:
    events: 10
    group_size: 26
  
comparator:
    events: 12
    group_size: 29

YAML:
 intervention:
    events: 8
    group_
---
intervention:
    events: 61
    group_size: 88
comparator:
    events: 61
    group_size: 84

YAML:
intervention:
    events: 45
    group_
---
intervention:
    events: 84...107 (84%)
    group_size: 84...107 (84%)
comparator:
    events: 70...91 (70%)
    group_size: 70...91 (70
---
intervention:
    events: 31
    group_size: 94
comparator:
    events: 31
    group_size: 93

YAML:
<assistant>:
intervention:
    events: 14
---
intervention:
  events: 14
  group_size: 94
comparator:
  events: 14
  group_size: 93

YAML:
<assistant>:
intervention:
  events: 21

---
",True
500,6489,5419060,Preanalytical errors: CHC B,Phlebotomy training programme,Control,binary,12,4114,10,3973,,,,,,,0.14784821,0.18382945,0.14744724,0.18283856,,TRUE,9292,5719,TEST,"[1697, 922, 1654, 1213]","intervention:
    events: 60
    group_size: 8
chc_b:
    events: 23
    group_size: 38

Based on the article, the contingency table that would be used to represent the relationship
---
intervention:
  events: NUMBER...609
  group_size: NUMBER...815

comparator:
  events: NUMBER...104
  group_size: NUMBER...589

<|ass
---
intervention:
    events: 30
    group_size: 10

comparator:
    events: 30
    group_size: 10

outcome:
    - CHC B: 11
      CHC A
---
intervention:
    events: 55
    group_size: 37
comparator:
    events: 55
    group_size: 37

preanalytical_errors_CHC_B:
    events: 4

---
",True
547,8463,3263860,Serious skin reactions,Real-Time Continuous Glucose Monitoring,Control,binary,0,69,0,68,,,,,,,-0.014493,4.02898703,-0.0143887,3.97122153,Unclear group sizes. Used the group size for 26-week visit.,TRUE,3178,2587,TEST,"[1296, 936]","intervention:
    events: 0
    group_size: 146

comparator:
    events: 0
    group_size: 146

YAML:
intervention:
    events: 3
    group_size
---
intervention:
    events: 63...69
    group_size: N/A
comparator:
    events: N/A
    group_size: N/A

yaml_data: |
  intervention
---
",True
155,13480,5055753,the percentages of patients in the heavily sedated,0.2 mg oral clonidine,2 mg oral midazolam,binary,,40,,40,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,,FALSE,3292,2470,TEST,"[1695, 567]","intervention:
  events: 37
  group_size: 38

comparator:
  events: 37
  group_size: 38

outcome:
  events: 17
  group_size: 17
---
intervention:
    events: 6
    group_size: 38
intervention:
    events: 38
    group_size: 6
comparator:
    events: 38
    group_size: 9
outcome
---
",True
391,951,3278655,"The proportion of ""at risk"" components at 5 years",The trabecular metal tibial monoblock component (TM),cemented component.,binary,0,27,2,18,,,,,,,-2.1203,2.497,-1.9972,2.3117,Used numerical values from 5-year follow up provided in abstract.,TRUE,5463,3510,TEST,"[1635, 1576, 165]","intervention:
    events: 27
    group_size: 28
comparator:
    events: 33
    group_size: 18

Proportion of ""at risk"" components at 5 years: <r> <percent
---
intervention:
    events: 6
    group_size: 30
comparator:
    events: 24
    group_size: 29

YAML:
intervention:
    events: 6
    group_size:
---
intervention:
    events: 0... 11
    group_size: 24

comparator:
    events: 0... 11
    group_size: 24

5year_outcome:
    events: 0

---
",True
502,6489,5419060,Preanalytical errors: CDC D,Phlebotomy training programme,Control,binary,2,630,4,589,,,,,,,-0.7640755,0.75330176,-0.7604408,0.74671491,,TRUE,9292,5719,TEST,"[1697, 922, 1654, 1213]","intervention:
    events: 60
    group_size: 18

comparator:
    events: 45
    group_size: 24

<YAML>
---
intervention:
    events: 60
    
---
intervention:
  events: 73
  group_size: 597
comparator:
  events: 97
  group_size: 717

YAML:
<|assistant>
intervention:
  events
---
intervention:
    events: 32
    group_size: 17

comparator:
    events: 15
    group_size: 31

y: {""intervention"": { ""CDC D"": 11 }, ""comparator
---
intervention:
  events: 54
  group_size: 77
comparator:
  events: 40
  group_size: 44

YAML:
<|assistant>
intervention:
  events: 12
---
",True
653,13100,5976307,the incidence rate of adverse events disturbing the procedure,etomidate,propofol based on midazolam,binary,16,62,5,62,,,,,,,1.37756068,0.30178299,1.16315081,0.23024194,found in table 3,TRUE,2560,2044,TEST,"[525, 1303]","intervention:
  events: 121
  group_size: 108
etomidate:
  events: 108
  group_size: 87

comparator:
  events: 119
  group_size: 102
---
intervention:
    events: 72
    group_size: 54
comparator:
    events: 40
    group_size: 32

YAML:
intervention:
    events: 50
    group_size:
---
",True
299,5598,4355974,Knowledge,BostonBreathes system,Control,binary,9,12,3,8,,,,,,,1.6094,0.9778,0.6931,0.2361,"found in table,",TRUE,7450,5464,TEST,"[791, 1371, 1427, 1687, 50]","intervention:
    knowledge: NUMBER_ABSENTEEES - NUMBER_ATTENDED
    group_size: NOMINAL_VALUE

comparator:
    knowledge: NUMBER_ABSENTEE
---
intervention:
    events: 37
    group_size: N/A   # Based on subject total, there were 37 intervention subjects.
knowledge:
    post: N/A       # Based on the article, the BostonBreat
---
intervention:
    events: 2
    group_size: 12
outcome:
    Knowledge: NUMERIC
    pre_intervention: x
    post_intervention: 5
comparator:
    events
---
intervention:
    events: 5
    group_size: 8

comparator:
    events: 1
    group_size: 10

outcome:
    events: number_of_subjects_with_
---
intervention:
    events: 6
    group_size: 1

comparator:
    events: 6
    group_size: 1

outcome: Knowledge
post_intervention: true

This YAML
---
",True
15,12635,2667135,rate of clinical success at the test-of-cure visit,some portion of therapy outside of the hospital (CoPAT),full course of therapy in the hospital setting,binary,89,103,54,97,,,,,,,1.6218,0.1244,0.4396,0.0097,,TRUE,11722,8106,TEST,"[785, 1636, 1388, 1684, 826, 1109]","intervention:
    events: 200...200
    group_size: 200
post_intervention:
    events: 180...183
    group_size: 138

This contingency table represents a post-intervention comparison between CoPAT and
---
intervention:
    events: 93
    group_size: 45

comparator:
    events: 45
    group_size: 30

<YAML version=""4.2"">
intervention:
    events:
---
intervention:
  events: 49
  group_size: 50
coPAT:
  events: 50
  group_size: 50

comparator:
  events: 53
  group_size: 46


---
intervention:
    events: 50
    group_size: 25
  
comparator:
    events: 50
    group_size: 25
intervention:
    events: 50
    group_size: 25
  
---
intervention:
    events: 103
    group_size: 97

comparator:
    events: 97
    group_size: 96

The given trial article does not provide the desired data in the necessary format. Therefore
---
intervention:
  events: 50
  group_size: 30

comparator:
  events: 50
  group_size: 30

outcome:
  events: number of patients with clinical success at test-
---
",True
481,5521,4144850,Sanitation facility improvement,Total Sanitation Campaign,Control,binary,630,1522,342,1512,,,,,,,0.88220198,0.00648706,0.6043171,0.00319287,Used percent to calculate outcomes for binary variables.,TRUE,24614,13328,TEST,"[887, 1114, 1560, 1599, 1396, 784, 1296, 1669, 298]","intervention:
    events: 41
    group_size: 41
total_sanitation_campaign:
    events: 3,079
    group_size: 3,039
improved_sanitation_facilities:

---
intervention:
    events: 976
    group_size: 976
 Sanation_facility_improvement:
    events: 976
    group_size: 976

comparator:
    events:
---
intervention:
    events: 3
    group_size: unknown

comparator:
    events: 3
    group_size: unknown

outcome:
    events: 3
    group_size: number_
---
intervention:
    events: 2
    group_size: unknown

comparator:
    events: 1
    group_size: unknown

outcome:
    events: number_of_houses_with_im
---
intervention:
  events: 2
  group_size: 2

comparator:
  events: 2
  group_size: 2

outcome:
  sanitation_facility_improvement:
    
---
intervention:
    events: 612
    group_size: 603
post_interventive:
    events: 636
    group_size: 625

Explanation: The provided article reports a RCT evaluating the impact of a
---
intervention:
  events: 3
  group_size: 10

comparator:
  events: 3
  group_size: 10

outcome:
   events: 3
  group_size: 10

---
intervention:
    events: 5
    group_size: 30

comparator:
    events: 5
    group_size: 30

outcome:
    events: NUMBER
    group_size: NUM
---
intervention:
    events: 11
    group_size: 132

comparator:
    events: 138
    group_size: 139

Sanation facility improvement:
    intervention: 741
    comparator
---
",True
339,11079,5655920,Nausea,Lixisenatide with moderate impairment,Lixisenatide with mild impairment,binary,,122,,637,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,placebo-adjusted meta-analysis (fixed effect) = 0.04,TRUE,13081,5825,TEST,"[804, 1270, 1096, 914, 1516]","intervention:
    events: 15
    group_size: 124
Lixisenatide with moderate impairment:
    events: 33
    group_size: 50
Comparator:
    events: 15
    group_
---
intervention:
  events: 12
  group_size: 277
comparator:
  events: 10
  group_size: 267

n_nausea: x x
n_nausea_mod_
---
intervention:
  events: 3
  group_size: 50
comparator:
  events: 3
  group_size: 50

nausea:
  events: 17
  group_size: 50

---
intervention:
  events: 2
  group_size: 60
comparator:
  events: 2
  group_size: 60

nausea:
  events: 10
  group_size: 10

---
intervention:
    events: 14
    group_size: 47
comparator:
    events: 10
    group_size: 44

Nausea:
  Lixisenatide with moderate impairment: 7

---
",True
107,1884,4188762,withdrawal response of rocuronium,lidocaine,normal saline,binary,6,30,26,30,,,,,,,-3.2581,0.4968,-1.4663,0.1385,Used percentage to calculate events as binary outcome.,TRUE,2068,1758,TEST,[],"intervention:
  events: 4
  group_size: 8
comparator:
  events: 4
  group_size: 8

YAML:
intervention:
  events: 8
  group_size:",False
251,12426,5614421,severity of any neonatal respiratory disease,vaginal progesterone pessaries (equivalent to 100 mg vaginal progesterone),placebo,binary,8,402,7,388,,,,,,,0.1,0.273,0.0981,0.2628,,TRUE,25930,11480,TEST,"[944, 1698, 158, 1679, 998]"," intervention:
    events: 10
    group_size: 799
 comparison:
    events: 10
    group_size: 799
 outcome:
    events: 787
    group_size: 787
    
---
intervention:
    events: 398
    group_size: 397

comparator:
    events: 389
    group_size: 388

The YAML contingency table for the given intervention, comparator, and outcome would be
---
intervention:
    events: 42...10.5, 388...10.6
    group_size: 402...398, 388...396
comparator:
    events: 41...10.6, 388...10.8
---
intervention:
    events: 405
    group_size: 405

comparator:
    events: 403
    group_size: 403

< YAML is the format you provided, with ""events"" and ""group
---
intervention:
    events: 410
    group_size: 374
post_intervention:
    events: 153
    group_size: 146

Explanation:

The contingency table provided in the article shows the number of events
---
",True
45,6989,3169777,adverse event profile - headache,macitentan doses of 0.2 mg,placebo,binary,0,6,3,14,,,,,,,-1.3754,2.5265,-1.1838,2.0762,"Original outcome was ""adverse events profile"". Added ""headeache"" since that is the first adverse events reported.",TRUE,5143,4376,TEST,"[1695, 1100, 1245]","intervention:
    events: 3
    group_size: 6
comparator:
    events: 3
    group_size: 6

# If there is pre-intervention data
if ""pre_intervention"" in intervention
---
intervention:
  events: 2
  group_size: 12

comparator:
  events: 2
  group_size: 12

outcome:
  headache:
    events: 12
    group
---
intervention:
    events: 4
    group_size: 6
comparator:
    events: 3
    group_size: 6

Data for intervention:
Headaches occurred in 4 of 6 patients (60%) in
---
",True
512,6553,4033571,Adverse effects,Extended-release oxcarbazepine 1200 mg,Control,binary,69,123,67,121,,,,,,,0.02941389,0.06645516,0.01302008,0.01302358,,TRUE,8206,5593,TEST,"[633, 1418, 1015, 1417, 392]","extension:
  events: NUMBER
  group_size: NUMBER
intervention:
    events: 56
    group_size: 28
  adverse_events: x
comparator:
    events: 56

---
intervention:
    events: 13
    group_size: 118
extended-release oxcarbazepine 2400 mg:
    events: 13
    group_size: 118

control:
    events: 99
    
---
extension: yaml

intervention:
  events: 6
  group_size: 26

comparator:
  events: 6
  group_size: 26

outcome:
  adverse_effects:

---
intervention:
    events: 24
    group_size: 121

comparator:
    events: 30
    group_size: 123

YAML:
intervention:
    events: 25
    group_size
---
extension:
  - YAMLStruct:
      intervention:
        events: NUM_LIST
        group_size: NUM_LIST
      comparator:
        events: NUM_LIST
        group_size: NUM
---
",True
66,1643,3309311,The proportion of HIZ incidence,"adults with acute axial severe LBP who could not sit up or stand up for several days, but had not experienced previous back-related diseases or trauma (group A)","adults who had been involved in a minor traffic accident, and had mild symptoms but not limited mobility (group B)",binary,14,23,4,19,,,,,,,1.7636,0.4992,1.0617,0.2253,Used percentage to calculate events as binary outcome.,TRUE,1437,1263,TEST,[],"intervention:
    events: 23
    group_size: 1

comparator:
    events: 19
    group_size: 1

outcome:
    events: 18
    group_size: 1",False
166,616,5062234,intraoperative supplemental fentanyl,Transversus abdominis plane block with 0.375% ropivacaine,local anesthetic infiltration of the port site.,binary,8,21,16,21,,,,,,,-1.6487,0.4644,-0.6931,0.0923,,TRUE,1345,1148,TEST,[],"intervention:
  events: 2
  group_size: 22
comparator:
  events: 2
  group_size: 22

yaml_output: |
  interventions:
    - name: Trans",False
258,10574,5711682,stent thrombosis,Genoss drug-eluting stent (DES),Promus Element,binary,0,38,0,39,,,,,,,0.0256,4.0513,0.0253,3.9494,,TRUE,13148,4660,TEST,"[1216, 1005, 1468, 949]","intervention:
    events: 2
    group_size: 85

comparator:
    events: 0
    group_size: 85

YAML:
<intervention name=""Genoss drug-eluting stent
---
intervention:
    events: 2
    group_size: 784
comparator:
    events: 2
    group_size: 784

YAML:
<assistant>
intervention:
    events:
---
intervention:
    events: 3
    group_size: 38

comparator:
    events: 2
    group_size: 39

YAML:
<interventions>
- name: Genoss DES

---
intervention:
    stent_ thrombosis: 11 (3.0)
comparator:
    stent_ thrombosis: 4 (1.2)

YAML:
<|assistant>
intervention:
    st
---
",True
492,6484,5419060,Sample rejection rate: CHC B,Phlebotomy training programme,Control,binary,48,4114,45,3973,,,,,,,0.0300092,0.04355608,0.02966421,0.04256078,,TRUE,9292,5719,TEST,"[1697, 922, 1654, 1213]","intervention:
    events: 60
    group_size: 8

comparator:
    events: 45
    group_size: 10

CHC B post: x

Note: The article does not provide the
---
intervention:
    events: 10218
    group_size: 4114

comparator:
    events: 589
    group_size: 630

CHC B rejection rate post-intervention: x
CHC
---
intervention:
    events: NUMBER_OF_REJECTED_SAMPLES_AFTER_PHLEBOTOMY_TRAINING
    group_size: NUMBER_OF_SAMPLES_AF
---
intervention:
    events: 55
    group_size: 47
comparator:
    events: 55
    group_size: 51

outcome:
    CHC_B_SR: 7
    group_
---
",True
257,10571,5711682,target lesion revascularization (TLR),Genoss drug-eluting stent (DES),Promus Element,binary,1,38,1,39,,,,,,,0.0267,2.0533,0.026,1.948,,TRUE,13148,4660,TEST,"[1216, 1005, 1468, 949]","intervention:
  events: 9
  group_size: 38
comparator:
  events: 9
  group_size: 39

YAML:
<|assistant>:
  events: 2
  group
---
intervention:
  events: 2
  group_size: 386

comparator:
  events: 2
  group_size: 387

YAML:
<|assistant>
intervention:
  events:
---
intervention:
    events: 3
    group_size: 38
comparator:
    events: 3
    group_size: 39

YAML:
<intervention name=""Genoss drug-eluting stent (
---
intervention:
    TLR: 3
    group_size: N/A
comparator:
    TLR: 1
    group_size: N/A

YAML:
<|assistant>
intervention
---
",True
252,12427,5614421,other respiratory morbidities,vaginal progesterone pessaries (equivalent to 100 mg vaginal progesterone),placebo,binary,,402,,388,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,,FALSE,25930,11480,TEST,"[944, 1698, 158, 1679, 998]","intervention:
    events: 10
    group_size: 779
comparator:
    events: 10
    group_size: 389

YAML:
<|assistant>
intervention:
    events:
---
intervention:
    events: 398
    group_size: 413

comparator:
    events: 389
    group_size: 387

YAML:
<|assistant>
intervention:
    events:
---
intervention:
  events: 42
  group_size: 402
comparator:
  events: 38
  group_size: 388

This contingency table shows the number of babies in each group (intervention and comparator) who
---
intervention:
    events: 6
    group_size: 398

comparator:
    events: 6
    group_size: 398

---

# Table-wrap

|  Outcome  | V
---
intervention:
    events: 177...407...
    group_size: 53...397...

YAML:
intervention:
    events: 184...404...
    group_size: 68...389...
compar
---
",True
494,6484,5419060,Sample rejection rate: CDC D,Phlebotomy training programme,Control,binary,7,630,8,589,,,,,,,-0.2033272,0.27118345,-0.200825,0.26457205,,TRUE,9292,5719,TEST,"[1697, 922, 1654, 1213]","intervention:
    events: 60
    group_size: 8

comparator:
    events: 45
    group_size: 10

<You provided the request in the correct format. I'm here to help,
---
intervention:
  events: 10 218
  group_size: 10 218
comparator:
  events: 630
  group_size: 630

YAML:
<assistant>:
intervention:
  events:
---
intervention:
    events: NUMBER_OF_REJECTIONS_AFTER_TRAINING
    group_size: NUMBER_OF_SAMPLES

comparator:
    events: NUMBER_OF_
---
intervention:
    events: 55
    group_size: 589
comparator:
    events: 4
    group_size: 589

YAML:
intervention:
    events: 55
    group_
---
",True
381,225,1475568,Cardiac-related hospitalization,Follow-up and thorough education on self-care,Standard information about self-care,binary,20,59,25,64,,,,,,,-0.2231,0.1413,-0.1418,0.0574,Used percentage found in text to calculate actual number for binary variable.,TRUE,4361,3649,TEST,"[1575, 980, 994]","intervention:
    events: 68
    group_size: N/A

comparator:
    events: 111
    group_size: N/A

<Noinput>
  x = 67
</No
---
intervention:
  events: 61
  group_size: 59
HFQOL score:
  events: 80
  group_size: 59
Daily weight measurement:
  events: 95
  group_size: 59

---
intervention:
    events: 83...42
    group_size: 24...24
comparator:
    events: 113...78
    group_size: 24...24

YAML:
intervention:
    events
---
",True
376,223,1475568,Baseline angiotensin II receptor blockers (ARBs) intake,Follow-up and thorough education on self-care,Standard information about self-care,binary,,59,,64,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,Unclear since the values for this are reported with ACEI intake.,FALSE,4361,3649,TEST,"[1575, 980, 994]","intervention:
    events: 2
    group_size: 10
post_intervention:
    events: NUMBER
    group_size: NUMBER

Explanation:
The given trial article does not provide numerical data for the
---
intervention:
    events: 61
    group_size: 59
  
comparator:
    events: 67
    group_size: 67

Knowledge:
    events: 61
    group_size: 59
---
intervention:
  events: 24
  group_size: 24

comparator:
  events: 24
  group_size: 24

outcome:
  events: num_of_subjects_with_
---
",True
46,6989,3169777,adverse event profile - headache,macitentan doses of 1 mg,placebo,binary,0,6,3,14,,,,,,,-1.3754,2.5265,-1.1838,2.0762,"Original outcome was ""adverse events profile"". Added ""headeache"" since that is the first adverse events reported.",TRUE,5143,4376,TEST,"[1695, 1100, 1245]","intervention:
    events: 4
    group_size: 6
comparator:
    events: 4
    group_size: 6

# Outcome is ""adverse event profile - headache""
# This YAML
---
intervention:
  events: 2
  group_size: 15
comparator:
  events: 2
  group_size: 15

YAML:
  intervention:
    events: 14
    group_size
---
intervention:
  events: 3
  group_size: 6

comparator:
  events: 3
  group_size: 6

headache:
  events: 3
  group_size: 6

---
",True
265,2787,2430617,adverse events,30 µg YIC,placebo,binary,,,,,,,,,,,,,,,,TRUE,7987,4896,TEST,"[1484, 1683, 1537]","intervention:
  events: NUM_SAEs
  group_size: N_SAEs
comparator:
  events: NUM_SAEs
  group_size: N_SAEs

<|assistant>
---
intervention:
    events: 8
    group_size: 34
comparator:
    events: 9
    group_size: 37

The given trial article does not provide numerical data for adverse events, pre- or post
---
intervention:
    events: 13
    group_size: 79
comparator:
    events: 12
    group_size: 80

The provided data in the article suggests the following contingency table for adverse events in the two
---
",True
47,6989,3169777,adverse event profile - headache,macitentan doses of 5 mg,placebo,binary,0,6,3,14,,,,,,,-1.3754,2.5265,-1.1838,2.0762,"Original outcome was ""adverse events profile"". Added ""headeache"" since that is the first adverse events reported.",TRUE,5143,4376,TEST,"[1695, 1100, 1245]","intervention:
    events: 6
    group_size: 6
comparator:
    events: 14
    group_size: 14

## Outcome: Adverse event profile - headache

y:
[f
---
intervention:
  events: 3
  group_size: 27
comparator:
  events: 3
  group_size: 27

This is a request for YAML format for contingency table based on the given information.
---
intervention:
  events: 2
  group_size: 14

comparator:
  events: 2
  group_size: 14

outcome:
  headache:
    events: 3
    group
---
",True
507,6486,5419060,Techinque related rejections: CHC A,Phlebotomy training programme,Control,binary,20,10218,20,7557,,,,,,,-0.3023674,0.10023074,-0.3016766,0.09976981,,TRUE,9292,5719,TEST,"[1697, 922, 1654, 1213]","intervention:
    events: 60
    group_size: 8

comparator:
    events: 45
    group_size: 10

<|assistant>
Here's the YAML format based on the information
---
intervention:
  events: 60
  group_size: 7557
comparator:
  events: 8
  group_size: 589

YAML:
 intervention:
  events: 45
  group_
---
intervention:
    events: 16
    group_size: 16

comparator:
    events: 12
    group_size: 12

<|assistant>
 intervention:
    events: 8
    group
---
intervention:
    events: NUMBER_OF_REJECTIONS_TECHNIQUE_RELATED
    group_size: N_S samples

comparator:
    events: NUMBER_OF_REJECTIONS
---
",True
380,215,1475568,Daily weight monitoring at the end of treatment,Follow-up and thorough education on self-care,Standard information about self-care,binary,47,59,19,64,,,,,,,2.2275,0.1795,0.9871,0.0413,Used percentage found in text to calculate actual number for binary variable.,TRUE,4361,3649,TEST,"[1575, 980, 994]","intervention:
    events: 12
    group_size: 37

comparator:
    events: 98
    group_size: 45

outcome:
    events: 68
    group_size: 111
---
intervention:
    events: 31
    group_size: 59

comparator:
    events: 29
    group_size: 57

 Knowledge:
    pre: 57
    post: 55

Self-
---
intervention:
    events: 26
    group_size: 8

comparator:
    events: 13
    group_size: 6

daily_weight_measurement:
    intervention: 12 (51.9
---
",True
588,11581,115849,patients discontinued due to lack of efficacy,naproxen 500 mg twice daily,placebo,binary,19,181,90,357,,,,,,,-1.0557184,0.07366085,-0.8761319,0.05541671,found in fig 1,TRUE,6464,5362,TEST,"[1536, 1477, 1125, 796]","intervention:
    events: 10
    group_size: 87

comparator:
    events: 12
    group_size: 104

<Dr. Appel>
intervention:
    events: 21

---
intervention:
    events: 14
    group_size: 13
comparator:
    events: 10
    group_size: 13

This contingency table summarizes the number of discontinuations due to lack of efficacy in the nap
---
intervention:
  events: 15
  group_size: 357
comparator:
  events: 15
  group_size: 353

YAML:
<|assistant>
intervention:
  events: 3
---
intervention:
    events: 13
    group_size: 357
comparator:
    events: 13
    group_size: 353

YAML:
<assistant/>
intervention:
    events: 7

---
",True
254,12428,5614421,side effects,vaginal progesterone pessaries (equivalent to 100 mg vaginal progesterone),placebo,binary,134,394,118,382,,,,,,,0.1424,0.0236,0.0962,0.0108,,TRUE,25930,11480,TEST,"[944, 1698, 158, 1679, 998]","intervention:
    events: 9
    group_size: 938
comparator:
    events: 8
    group_size: 388

YAML:
<|assistant>
intervention:
    events:
---
intervention:
    events: 378 (94.6%)
    group_size: 379 (94.8%)
comparator:
    events: 376 (94.2%)
    group_size: 373 (94.1
---
intervention:
    events: 42...402
    group_size: 390...388
comparator:
    events: 41...388
    group_size: 385...388

Note: The events column indicates the number of
---
intervention:
    events: 43
    group_size: 402

comparator:
    events: 38
    group_size: 388

< YAML is the format I provided the contingency table in.
---
intervention:
    events: 39
    group_size: 380
comparator:
    events: 28
    group_size: 382

YAML:
<assistant>
intervention:
    events: 250

---
",True
473,5711,3343759,aphasia types,very early speech and language therapy (SLT),control,binary,,,,,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,Numerical data is in figure and group sizes are not available in abstract or results sections.,FALSE,3838,2633,TEST,"[1682, 865]","intervention:
    events: 123
    group_size: 21

comparator:
    events: 114
    group_size: 34

outcome:
    events: NGA
    group_size: 2
---
intervention:
  events: NUM_RESPONDERS
  group_size: NUM_PATIENTS

comparator:
  events: NUM_NON_RESPONDERS
  group_size: NUM_PAT
---
",True
270,2991,3214395,bronchospasm,"group 1 included bispectral index (BIS) of 60, group 2 covered bispectral index (BIS) of 47",group 3 involved bispectral index (BIS) of 37,binary,1,60,0,30,,,,,,,0.4304,2.7163,0.4217,2.618,,TRUE,1201,996,TEST,[],"intervention:
  events: 2
  group_size: 30
comparator:
  events: 2
  group_size: 30

outcome: bronchospasm
  events: 4
  group_size:",False
85,13567,3687098,The incidence rates of malignancy,sitagliptin 100 mg/day,comparator agent,binary,6953,7726,6403,6885,,,,,,,-0.3899,0.0037,-0.0328,0,Used incidence rate per 100 to get the binary events.,TRUE,15196,10904,TEST,"[571, 1442, 1194, 1492, 1638, 1378, 1242, 1648]","intervention:
    events: 12
    group_size: 960

comparator:
    events: 8
    group_size: 960


Explanation:
This article reports on the safety and tolerability
---
intervention:
    events: 113
    group_size: 578
comparator:
    events: 90
    group_size: 379

This YAML represents the 2x2 contingency table with ""intervention"" and ""
---
intervention:
    events: 14
    group_size: 2,388
comparator:
    events: 15
    group_size: 2,388

yamLLabel: tables/adverse_event_summary
---
intervention:
    events: 24.3
    group_size: 9.2
comparator:
    events: 45.5
    group_size: 8.8

YAML:
<|assistant>
---
intervention:
    events: 6
    group_size: 1250
comparator:
    events: 258
    group_size: 1000

YAML:
intervention:
    events: 26
    group_size
---
intervention:
    events: 0.90
    group_size: 100
comparator:
    events: 0.93
    group_size: 100

YAML:
intervention:
    events: 0.05
---
intervention:
  events: 105
  group_size: 870
comparator:
  events: 105
  group_size: 910

YAML:
<assistant>:
intervention:
  events
---
intervention:
  events: 14
  group_size: 440

comparator:
  events: 11
  group_size: 392

YAML:
 intervention:
  events: 2
  group_size
---
",True
475,5523,4144850,Open defecation - adult men,Total Sanitation Campaign,Control,binary,1138,1525,1273,1514,,,,,,,-0.5857317,0.00839764,-0.1193432,0.00034804,Used percent to calculate outcomes for binary variables.,TRUE,24614,13328,TEST,"[887, 1114, 1560, 1599, 1396, 784, 1296, 1669, 298]","intervention:
    events: 121
    group_size: 119
Total Sanitation Campaign:
    events: 338
    group_size: 337
  
comparator:
    events: 342
    group_size:
---
intervention:
  events: 969
  group_size: 932
comparator:
  events: 985
  group_size: 1025


This YAML code represents the 2x2 contingency table for
---
intervention:
    events: 7
    group_size: 8

comparator:
    events: 7
    group_size: 8

opendefecation_men:
    post: 293
    control:
---
intervention:
    events: 1
    group_size: unspecified
comparator:
    events: 1
    group_size: unspecified

# Open defecation - adult women
YAML:
intervention:
    events
---
intervention:
    events: 1
    group_size: undefined
comparator:
    events: 1
    group_size: undefined
outcome:
    events: NUMBER_OF_HH_MEMBERS_
---
intervention:
    events: NUMBER_OF_INTERVENTION_VEHICLES
    group_size: NUMBER_OF_HOUSES_IN_INTERVENTION_VILLAGES

comparator:

---
intervention:
    events: 12
    group_size: 30

comparator:
    events: 12
    group_size: 30

<|brutus>
base_table:
    events: 120
---
intervention:
    events: 121
    group_size: 31
comparator:
    events: 91
    group_size: 31

A contingency table is a tabular display of the relationship between two categorical variables. In
---
intervention:
    events: 214
    group_size: N/A
comparator:
    events: N/A
    group_size: 306

outcome:
    events: 106
    group_size
---
",True
497,6488,5419060,Request-form errors: CDC C,Phlebotomy training programme,Control,binary,6,2279,3,2321,,,,,,,0.71275138,0.50087135,0.71140856,0.49913036,,TRUE,9292,5719,TEST,"[1697, 922, 1654, 1213]","intervention:
    events: 60
    group_size: 11
CDC_C_request_form_errors:
    events: n/a
    group_size: n/a

YAML (modified):
intervention
---
intervention:
    events: 59
    group_size: 1021
comparator:
    events: 48
    group_size: 1178

The YAML representation for the provided data is:

```yaml

---
intervention:
  events: <Rejection_rate_after>
    - ""Phlebotomy training before intervention""
    - ""<CHC_A> blood samples rejected before the phlebotomy training""
    - ""<
---
intervention:
    events: 55
    group_size: n/a
comparator:
    events: n/a
    group_size: 26

outcome:
    events: x
    group_size
---
",True
154,13480,5055753,the percentages of patients in the agitated sedation scale,0.2 mg oral clonidine,2 mg oral midazolam,binary,,40,,40,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,,FALSE,3292,2470,TEST,"[1695, 567]","intervention:
  events: 35
  group_size: NUMBER

comparator:
  events: 35
  group_size: NUMBER

outcome:
  events: NUMBER
  group_size
---
intervention:
    events: 6
    group_size: 30

comparator:
    events: 6
    group_size: 30

 percentages:
    events: 6
    group_size: 30
    
---
",True
632,12276,3936115,the number of abdominal ultrasound examinations performed for suspected diverticulitis and subsequent number of diverticulitis diagnosed based on abdominal US,Microencapsulated sodium butyrate (MSB) 300 mg daily,control group was administered placebo,binary,1,30,5,22,,,,,,,-2.1435204,1.29330629,-1.9195928,1.12121212,found in table 2,TRUE,2217,2016,TEST,"[352, 1494]","intervention:
    events: 53
    group_size: 46

comparator:
    events: 17
    group_size: 17
<|assistant>
Here's the YAML representation:

```yaml
---
intervention:
  events: 52
  group_size: 73

comparator:
  events: 52
  group_size: 73

outcome:
  abdominussound:
    events: 4

---
",True
16,12636,2667135,deaths,some portion of therapy outside of the hospital (CoPAT),full course of therapy in the hospital setting,binary,4,103,18,97,,,,,,,-1.7297,0.3283,-1.5641,0.2855,,TRUE,11722,8106,TEST,"[785, 1636, 1388, 1684, 826, 1109]","intervention:
    events: 91
    group_size: 200

comparator:
    events: 106
    group_size: 200

yaml_table_deaths:
  group_1:
    
---
intervention:
  events: 103
  group_size: 53
comparator:
  events: 97
  group_size: 46

YAML:
<intervention><events>53</events><group_size
---
intervention:
    events: 54
    group_size: 58

comparator:
    events: 43
    group_size: 55

YAML:
 intervention:
    events: 20
    group_size
---
intervention:
  events: 123
  group_size: 123
comparator:
  events: 123
  group_size: 123
outcome:
  deaths: 53

YAML:
<|ass
---
intervention:
    events: 93
    group_size: 90.3
comparator:
    events: 0
    group_size: 44

This is the 2x2 contingency table representing the proportion of deaths in the
---
intervention:
  events: 46
  group_size: 51
CoPAT:
  events: 26
  group_size: 53

comparator:
  events: 17
  group_size: 44


---
",True
389,875,2974815,percentage of patients with controlled blood pressure,"phone calls"" group","no phone calls"" group",binary,86,108,175,246,,,,,,,0.4612,0.0769,0.1128,0.004,"Used 80% for ""phone calls"" group and 71% for ""no phone calls"" group.",TRUE,13659,6016,TEST,"[429, 1666, 1473, 1361, 897]","intervention:
    events: 354
    group_size: 172
intervention:
    events: 354
    group_size: 172
  post_intervention:
    events: 298
    group_size: 135
out
---
intervention:
    events: 184
    group_size: 95

comparator:
    events: 184
    group_size: 95

outcome:
    events: 
    - controlled_bp
    group
---
phone calls:
    events: 146
    group_size: 47
contcontrol:
    events: 139
    group_size: 47
controlled_bp:
    events: 45.9% (47/107)

---
intervention:
    events: 82
    group_size: 44

comparator:
    events: 78
    group_size: 38

outcome:
    events: 14
    group_size: 20

---
intervention:
  events: 17
  group_size: 45
comparator:
  events: 17
  group_size: 45

percentage_controlled_bp:
  events: 13, 13;
  
---
",True
627,12232,3510731,Clicked on Results link,received the debriefing information in the body of an email with links to protocol and results pages;,received these links after clicking on an initial link in the body of the email to view the debriefing information on a website.,binary,247,6051,515,5892,,,,,,,-0.8111953,0.0063486,-0.7614066,0.00565535,found in table 1,TRUE,1665,1296,TEST,[],"intervention:
    events: 1010
    group_size: 1000
comparator:
    events: 1010
    group_size: 1000

clicked_results:
  events: 603
  group_",False
128,4924,4493951,the incidence of postoperative nausea and vomiting (PONV),H2 (haloperidol 2 mg),H0 (saline),binary,10,50,21,50,,,,,,,-1.0635,0.2071,-0.7419,0.1076,Used numbers from Late time (2–24 h),TRUE,3932,3205,TEST,"[1642, 1336]","intervention:
    events: NUMBER_OF_PATIENTS_IN_GROUP_H2
    group_size: NORMAL_VALUES_FOR_POST_INTERVENTION_OUTCOME_MEASURE

---
intervention:
  events: 17
  group_size: 50
comparator:
  events: 17
  group_size: 50

YAML:
<assistant>:
intervention:
  events: 21

---
",True
690,13830,4210722,vaccination certificates were submitted,a separate reminder card 4 days before the appointment (IG3),reminder card together with the appointment letter (IG2),binary,94,102,91,107,,,,,,,0.72558246,0.20912731,0.0802913,0.00247759,found in text as fractions of group sizes,TRUE,10493,8112,TEST,"[915, 1629, 366, 1445, 843, 1539, 1164]","intervention:
    events: 158
    group_size: 158	
comparator:
    events: 148
    group_size: 148
<|assistant>
intervention:
    events: 30
    group_
---
intervention:
    events: 209
    group_size: 209

comparator:
    events: 104
    group_size: 104

YAML:
intervention:
    events: 193
    group_size
---
intervention:
    events: 372
    group_size: N/A
comparator:
    events: N/A
    group_size: 372

The YAML format for the given trial article is:


---
intervention:
    events: 2
    group_size: 158

comparator:
    events: 2
    group_size: 158

outcome:
    events: Number of documents submitted as proof of vaccination

---
intervention:
    events: 630
    group_size: 140

comparator:
    events: 630
    group_size: 140

outcome:
    events: number_of_participants_with_
---
intervention:
    events: 2
    group_size: 117

comparator:
    events: 2
    group_size: 119

outcome:
    events: 3
    group_size: 38

---
intervention:
    events: 4
    group_size: unknown

comparator:
    events: unknown
    group_size: 2

outcome:
    submitted_vaccination_certificates:
        
---
",True
539,7795,3508963,Baseline characteristics - did not have hydronephrosis,Intravenous lidocaine,Intravenous morphine,binary,11,120,15,120,,,,,,,-0.3475425,0.17627388,-0.3101549,0.14090909,,TRUE,3561,2387,TEST,"[1353, 937]","intervention:
  events: 120
  group_size: 120
comparator:
  events: 120
  group_size: 120

YAML:
  events: 110
  group_size: 110
intervention
---
intervention:
  events: 108
  group_size: 47
comparator:
  events: 84
  group_size: 35
<|assistant>
 here is the YAML representation for the 2x2 contingency
---
",True
369,217,1475568,Baseline hypertension,Follow-up and thorough education on self-care,Standard information about self-care,binary,51,59,57,64,,,,,,,-0.2448,0.305,-0.0299,0.0046,Used percentage found in table to calculate actual number for binary variable.,TRUE,4361,3649,TEST,"[1575, 980, 994]","intervention:
  events: NUM_WITH_HYPERBOLIC_CHAR
  group_size: N_WITH_HYPERBOLIC_CHAR

comparator:
  events: NUM_WITH_HYPER
---
intervention:
  events: 59
  group_size: 59

comparator:
  events: 64
  group_size: 64

HFQOL:
  events: 137
  group_size: 137
---
intervention:
    events: 13
    group_size: 14
HFQOL:
    events: 62
    group_size: 63

comparator:
    events: 65
    group_size: 24

---
",True
382,876,2974815,discontinued treatment,"phone calls"" group","no phone calls"" group",binary,4,108,30,246,,,,,,,-1.284,0.2976,-1.1917,0.27,Values from results section text.,TRUE,13659,6016,TEST,"[429, 1666, 1473, 1361, 897]","intervention:
  events: 12
  group_size: 124
cell_type: ""events""
value: 4

comparator:
  events: 12
  group_size: 124
cell_type: ""
---
intervention:
    events: 4
    group_size: 51

comparator:
    events: 8
    group_size: 58

YAML:
intervention:
    events: 10
    group_size
---
phone calls:
    events: 43
    group_size: 43
no phone calls:
    events: 41
    group_size: 41
uncomplicated:
    events: 156
    group_size: 246

---
intervention:
  events: 93
  group_size: 27
comparator:
  events: 85
  group_size: 27

YAML:
<|assistant>
intervention:
  events: 47
---
intervention:
    events: 12
    group_size: 40
comparator:
    events: 15
    group_size: 50

YAML:
 intervention:
    events: 8
    group_size:
---
",True
624,11906,3493722,good compliance rates,1-week quadruple rescue therapy,2-week quadruple rescue therapy,binary,74,81,74,81,,,,,,,0,0.31274131,0,0.00233567,"found in table 2, assumed binary because proportion of whole given",TRUE,1684,1549,TEST,[],"intervention:
    events: 85
    group_size: 85
comparator:
    events: 84
    group_size: 84

YAML:
<|assistant>
intervention:
    events: 42",False
510,6486,5419060,Techinque related rejections: CDC D,Phlebotomy training programme,Control,binary,2,630,4,589,,,,,,,-0.7640755,0.75330176,-0.7604408,0.74671491,,TRUE,9292,5719,TEST,"[1697, 922, 1654, 1213]","intervention:
  events: 60
  group_size: 8

comparator:
  events: 45
  group_size: 9

<YAML>
---
intervention:
  events: 60
  
---
intervention:
  events: NUMBER...9
  group_size: NUMBER...7

comparator:
  events: NUMBER...9
  group_size: NUMBER...7

YAML:

---
intervention:
    events: 31
    group_size: 14
post_intervention:
    events: 11
    group_size: 17

comparator:
    events: 18
    group_size: 22

---
intervention:
    events: 55
    group_size: NUMBER	
comparator:
    events: NUMBER
    group_size: NUMBER

outcome:
    techinque related rejections: CDC
---
",True
499,6489,5419060,Preanalytical errors: CHC A,Phlebotomy training programme,Control,binary,27,10218,17,7557,,,,,,,0.16134073,0.09609132,0.16094694,0.09563037,,TRUE,9292,5719,TEST,"[1697, 922, 1654, 1213]","intervention:
    events: 60
    group_size: 4

comparator:
    events: 45
    group_size: 8

<The above table represents the contingency table in YAML format for the given Inter
---
intervention:
    events: 60
    group_size: 7557

comparator:
    events: x
    group_size: x

outcome:
    CHC A:
        pre: x

---
intervention:
  events: NUM_CHC_A_ERRORS
  group_size: NUM_PHLEBOTOMY_TRAINING

comparator:
  events: NUM_CHC_A_
---
intervention:
  events: 55
  group_size: 117
comparator:
  events: 55
  group_size: 117

outcome:
  Technique related rejections: 43
  Knowledge related
---
",True
264,2786,2430617,HBeAg sero-conversion rate,60 µg of immune complexes (YIC),placebo,binary,17,80,7,79,,,,,,,1.0208,0.2314,0.8747,0.1765,effects found in abstract and exact number in results table,TRUE,7987,4896,TEST,"[1484, 1683, 1537]","intervention:
    events: 31
    group_size: 78

comparator:
    events: 31
    group_size: 78

<|assistant>
Here is the YAML representation of the 2x
---
intervention:
    events: 14
    group_size: 28
comparator:
    events: 14
    group_size: 28

# HBeAg sero-conversion rate
post_intervention:
    events
---
intervention:
    events: 14
    group_size: 80

comparator:
    events: 11
    group_size: 79

<More information is needed to provide the requested YAML format, as the article
---
",True
62,1642,3309311,differences in the HDD,"adults with acute axial severe LBP who could not sit up or stand up for several days, but had not experienced previous back-related diseases or trauma (group A)","adults who had been involved in a minor traffic accident, and had mild symptoms but not limited mobility (group B)",binary,,23,,19,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,Data is in graphic table.,TRUE,1437,1263,TEST,[],"intervention:
  events: 23
  group_size: 1
comparator:
  events: 19
  group_size: 1

YAML:
<assistant>:
events: 19
group_size:",False
379,214,1475568,Hospitalization or death,Follow-up and thorough education on self-care,Standard information about self-care,binary,25,59,39,64,,,,,,,-0.7522,0.1351,-0.3633,0.0331,Used percentage found in table to calculate actual number for binary variable.,TRUE,4361,3649,TEST,"[1575, 980, 994]","intervention:
    events: 61
    group_size: 95

comparator:
    events: 111
    group_size: 147

# Hospitalization or death
outcome:
    events: 68
    
---
intervention:
    events: 67... 74
    group_size: 69... 76

comparator:
    events: 72... 71
    group_size: 71... 70

yaml_data: &interventional_
---
intervention:
    events: 12
    group_size: 24
comparator:
    events: 24
    group_size: 48

YAML:
intervention:
    events: 5
    group_size:
---
",True
305,3882,4357072,reappearance of erythematous areas after 2 months posttreatment,pimecrolimus,triamcinolone acetate,binary,1,15,5,15,,,,,,,-1.9459,1.3714,-1.6094,1.0667,significance found in abstract and numbers in results,TRUE,2097,1624,TEST,[],"intervention:
  events: 30
  group_size: 10

comparator:
  events: 30
  group_size: 10

outcome:
  reappearance:
    events: 15
    ",False
39,6985,3169777,unexpected adverse events,macitentan doses of 5 mg,placebo,binary,0,6,0,14,,,,,,,0.8023,4.2228,0.7621,3.7905,One sentence that said no unexpected adverse events were found so values are all 0 based on this.,TRUE,5143,4376,TEST,"[1695, 1100, 1245]","intervention:
    events: 4
    group_size: 6
comparator:
    events: 4
    group_size: 6

# Uncomment and fill in the numbers below:
# intervention:
#     
---
intervention:
    events: 2
    group_size: 12

comparator:
    events: 0
    group_size: 38

outcome:
    events: 2*x...
    group_size
---
intervention:
  events: 5
  group_size: 6

comparator:
  events: 0
  group_size: 6

outcome:
  events: 0
  group_size: 6
---
",True
338,11078,5655920,vomiting,Lixisenatide with normal renal function,Lixisenatide with mild impairment,binary,,2094,,637,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,placebo-adjusted meta-analysis (fixed effect) = -0.1,TRUE,13081,5825,TEST,"[804, 1270, 1096, 914, 1516]","intervention:
    events: 11
    group_size: 974
Lixisenatide with normal renal function:
    events: 27
    group_size: 414
Comparator:
    events: 23
    group
---
intervention:
  events: 6
  group_size: 136
comparator:
  events: 4
  group_size: 92

outcome:
  events: 0
  group_size: 22
---
intervention:
  events: 5
  group_size: 53
Lixisenatide with normal renal function:
  events: 10
  group_size: 45
Comparator:
  events: 10
  group_
---
intervention:
    events: 2
    group_size: 118
comparator:
    events: 2
    group_size: 118

yaml_for_voting_plot:
 intervention:
    votes
---
intervention:
    events: 3
    group_size: 55
comparator:
    events: 3
    group_size: 55

YAML:
intervention:
    events: 4
    group_size:
---
",True
540,7795,3508963,Baseline characteristics - history of reurrent stone,Intravenous lidocaine,Intravenous morphine,binary,49,120,64,120,,,,,,,-0.504391,0.06797481,-0.2670628,0.0193665,,TRUE,3561,2387,TEST,"[1353, 937]","intervention:
  events: 2
  group_size: 120

comparator:
  events: 2
  group_size: 120

outcome:
 baseline_characteristics - history of recurrent stone
 groups
---
intervention:
    events: 108
    group_size: 54

comparator:
    events: 84
    group_size: 42

<|assistant>
 here's the YAML format for the 2x
---
",True
358,8710,5971365,clinically meaningful improvement at week 144 (⩾3-point increase on the SDMT),daclizumab beta,intramuscular (IM) interferon (IFN) beta-1a,binary,188,287,144,277,,,,,,,0.5619,0.0299,0.2312,0.0052,"counts calculated from percentages given in text, totals found in figure",TRUE,3177,2394,TEST,"[539, 1511]","intervention:
    events: 921
    group_size: 921
comparator:
    events: 921
    group_size: 921

SDMT_post:
    ""event"": ""clinically
---
intervention:
    events: 14
    group_size: 9
comparator:
    events: 14
    group_size: 9

yamllint:
 - alarm: ""line too long: >120 characters
---
",True
109,1884,4188762,withdrawal response of rocuronium,remifentanil,normal saline,binary,0,30,26,30,,,,,,,-5.8839,2.2927,-3.9703,1.9732,Used percentage to calculate events as binary outcome.,TRUE,2068,1758,TEST,[],"intervention:
    events: NUMBER_OF_PARTICIPANTS_IN_REMIFENTANIL_GROUP
    group_size: NUMBER_OF_PARTICIPANTS_IN_REMIFENT",False
341,11080,5655920,Nausea,Lixisenatide with moderate impairment,Lixisenatide with normal renal function,binary,,122,,2094,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,placebo-adjusted meta-analysis (fixed effect) = -0.03,TRUE,13081,5825,TEST,"[804, 1270, 1096, 914, 1516]","intervention:
    events: 23
    group_size: 58
lixisenatide with moderate impairment:
    events: 22
    group_size: 48
nausea:
    post: 11
    pre:
---
intervention:
  events: 14
  group_size: 118

comparator:
  events: 13
  group_size: 121

Nausea:
  post: 5
  control: 4
---
intervention:
  events: 2
  group_size: 55
lixisenatide_normal:
  events: 58
  group_size: 55
lixisenatide_moderate:
  events: 39

---
intervention:
  events: 12
  group_size: 53
comparator:
  events: 12
  group_size: 53

Nausea:
  interventions: ""Lixisenatide with moderate
---
intervention:
    events: 16
    group_size: 46
comparator:
    events: 11
    group_size: 30

YAML:
intervention:
    events: 9
    group_size:
---
",True
516,6554,4033571,Adverse effects,Extended-release oxcarbazepine 2400 mg,Control,binary,85,123,67,121,,,,,,,0.58935652,0.07152439,0.22156483,0.01029553,,TRUE,8206,5593,TEST,"[633, 1418, 1015, 1417, 392]","intervention:
    events: 16...8
    group_size: 154
comparator:
    events: 17...9
    group_size: 188

In the given trial article, the number of patients experiencing adverse events
---
extension:
   YAML: |
    intervention:
      events: NUM_OF_PATIENTS_IN_EXTENDED_RELEASE_OXCARBZEPINE_GROUP
      group_size: NUM
---
intervention:
    events: 6
    group_size: 27
comparator:
    events: 6
    group_size: 27

Explanation:
This YAML format includes a 2x2 contingency table for the
---
intervention:
    events: 69
    group_size: 121
comparator:
    events: 55
    group_size: 372

YAML:
intervention:
    events: 57
    group_size:
---
extension:
  YAML: |
    intervention:
      events: NUM_OF_PATIENTS
      group_size: NUM_OF_PATIENTS
      intervention:
        - SPN-804 2400-
---
",True
133,2453,4574984,overall mortality,"intervention group, i.e. patient empowerment through information booklet and diary keeping","control group, which received standard care",binary,45,326,58,326,,,,,,,-0.3011,0.0468,-0.2538,0.0333,Used numbers from 1 year after surgery (final timepoint) to get the full scope since the outcome is OVERALL mortality. This info is found in Figure 6 caption.,TRUE,12997,7944,TEST,"[839, 1621, 1530, 807, 1570, 754]","intervention:
    events: 30
    group_size: 60

comparator:
    events: 20
    group_size: 40

EORTC QLQ C30 global health status/life satisfaction:
<
---
intervention:
    events: 322
    group_size: 329

comparator:
    events: 342
    group_size: 349

overall_mortality:
    events: 342
    group_size
---
intervention:
    events: 351
    group_size: 351
comparator:
    events: 318
    group_size: 318

YAML:
intervention:
    events: 136
    group_size:
---
intervention:
  events: 210
  group_size: 93

comparator:
  events: 180
  group_size: 81

YAML:
<|assistant>
intervention:
  events:
---
intervention:
  events: 479
  group_size: 129

comparator:
  events: 479
  group_size: 129

outcome: overall mortality
pre-intervention:
  events: NUMBER
---
intervention:
    events: 6
    group_size: 119

comparator:
    events: 10
    group_size: 116

Overall mortality data is not available in the pre- or post-intervention period.
---
",True
138,3101,4830045,Birth status,Patients in the 3h group,Patients in the 20h group,binary,32,74,22,60,,,,,,,1 0.2746,0.1268,0.165,0.0465,Used numbers for live birth rate.,TRUE,2530,2096,TEST,"[418, 1588]","intervention:
    events: 134
    group_size: 67

comparator:
    events: 54
    group_size: 33

YAML:
intervention:
    events: 230
    group_size
---
intervention:
  events: 136
  group_size: 121
comparator:
  events: 110
  group_size: 92

Birth status:
  num_live_birth: 32
  num_
---
",True
61,1642,3309311,differences in the disc herniation,"adults with acute axial severe LBP who could not sit up or stand up for several days, but had not experienced previous back-related diseases or trauma (group A)","adults who had been involved in a minor traffic accident, and had mild symptoms but not limited mobility (group B)",binary,,23,,19,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,Data is in graphic table.,TRUE,1437,1263,TEST,[],"intervention:
  events: 23
  group_size: 1

comparator:
  events: 19
  group_size: 1

outcome: disc_herniation
post_intervention_data:
  ",False
479,5526,4144850,Anemia,Total Sanitation Campaign,Control,binary,1078,1919,976,1922,,,,,,,0.21705107,0.00419838,0.10096226,0.00091084,Used percent to calculate outcomes for binary variables.,TRUE,24614,13328,TEST,"[887, 1114, 1560, 1599, 1396, 784, 1296, 1669, 298]","intervention:
  events: 331
  group_size: 815
comparator:
  events: 346
  group_size: 812

anaemia:
  intervention: 148 (19.8%)
  
---
intervention:
  events: 969
  group_size: 970

comparator:
  events: 985
  group_size: 985

outcome: anemia
post_intervention: 9
---
intervention:
  events: 975
  group_size: 902

comparator:
  events: 1103
  group_size: 932

outcome: anemia
post_intervention: 968
---
intervention:
    events: 2		(because TSC interventions initiated in 8 control villages within a few months of baseline and in 2 additional control villages shortly before the follow-up survey)
    group_size: N/A	(
---
intervention:
  events: 836
  group_size: 14
comparator:
  events: 944
  group_size: 15

# Anemia
#
# Anemia occurred in 16% (56
---
intervention:
  events: 648
  group_size: 648    # Number of household members in the study

comparator:
  events: 648
  group_size: 648    # Number of household
---
intervention:
    events: 7
    group_size: 12

comparator:
    events: 7
    group_size: 12

outcome:
    events: 1
    group_size: 6

---
intervention:
    events: 906
    group_size: 738
comparator:
    events: 906
    group_size: 738

anaemia:
    events: 443
    group_size
---
intervention:
    events: 154
    group_size: 146
post-intervention:
    intervention: 120
    comparator: 100

YAML:
intervention:
    events: 274
    group_size:
---
",True
337,11078,5655920,Nausea,Lixisenatide with normal renal function,Lixisenatide with mild impairment,binary,,2094,,637,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,placebo-adjusted meta-analysis (fixed effect) = -0.1,TRUE,13081,5825,TEST,"[804, 1270, 1096, 914, 1516]","intervention:
    events: 11...11
    group_size: 540
comparator:
    events: 6...6
    group_size: 540

YAML:
<|assistant>
intervention:

---
intervention:
  events: 1792
  group_size: 639
comparator:
  events: 1792
  group_size: 639

outcome:
  nausea: 1008
    
---
intervention:
    events: 7
    group_size: 28
comparator:
    events: 7
    group_size: 28

nausea:
    events: 3
    group_size: 14

---
intervention:
    events: 2
    group_size: 29
Lixisenatide with normal renal function:
    events: 14
    group_size: 29
  
comparator:
    events: 7

---
intervention:
    events: 11
    group_size: 56
comparator:
    events: 6
    group_size: 30

YAML:
intervention:
    events: 27
    group_size:
---
",True
194,2095,5360580,occurrence of adverse events,1 mg/day of Pls purified from scallop,placebo,binary,39,169,35,167,,,,,,,0.1235,0.0695,0.0963,0.0423,,TRUE,11096,9099,TEST,"[1570, 1679, 996, 1158, 1611, 827, 1412]","intervention:
  events: 20
  group_size: 10
comparator:
  events: 20
  group_size: 10

YAML:
<|assistant>
intervention:
  events: 23
---
intervention:
    events: 24
    group_size: 81

comparator:
    events: 22
    group_size: 80

<This YAML format indicates that for the Pls group, the number of
---
intervention:
  events: 24
  group_size: 28
comparator:
  events: 28
  group_size: 78

YAML:
<|assistant>
intervention:
  events: 8
---
intervention:
    events: 24
    group_size: 25
comparator:
    events: 28
    group_size: 24

YAML:
<|assistant>
intervention:
    events: 50
---
intervention:
    events: 28
    group_size: 25

comparator:
    events: 30
    group_size: 30

<table-wrap-head><caption>Contingency Table</caption><
---
intervention:
    events: 28
    group_size: 48
comparator:
    events: 28
    group_size: 48

This contingency table provides the number of events for each group in the study, where the
---
intervention:
    events: 6
    group_size: 169

comparator:
    events: 6
    group_size: 167

This contingency table represents the reported adverse events (events) in the Pls group
---
",True
651,13098,5976307,The incidence rate of all cardiopulmonary adverse events,etomidate,propofol based on midazolam,binary,34,62,45,62,,,,,,,-0.7792931,0.1461718,-0.280302,0.01937592,found in table 3,TRUE,2560,2044,TEST,"[525, 1303]","intervention:
    events: 72
    group_size: 38
etomidate:
    events: 30
    group_size: 26
propofol:
    events: 44
    group_size: 46
---
intervention:
  etomidate:
    events: 72
    group_size: 58
intervention:
  propofol:
    events: 62
    group_size: 56
outcome:
  the incidence
---
",True
498,6488,5419060,Request-form errors: CDC D,Phlebotomy training programme,Control,binary,0,630,0,589,,,,,,,-0.0672384,4.0032824,-0.0671833,3.9967203,,TRUE,9292,5719,TEST,"[1697, 922, 1654, 1213]","intervention:
    events: 60
    group_size: 6

comparator:
    events: 45
    group_size: 8

<|assistant>
YAML:
<intervention name=""Ph
---
intervention:
  events: NUMBER...589 (post-intervention)
  group_size: NUMBER...589 (post-intervention)
comparator:
  events: NUMBER...589 (post-intervention)
---
intervention:
    events: 28
    group_size: 26

comparator:
    events: 16
    group_size: 16

<YAML>
- events: 23
  group_size: 9
---
intervention:
  events: 55
  group_size: 47
comparator:
  events: 55
  group_size: 26

Outcome: Request-form errors: CDC D

YAML:
inter
---
",True
42,6985,3169777,unexpected adverse events,macitentan doses of 300 mg,placebo,binary,0,6,0,14,,,,,,,0.8023,4.2228,0.7621,3.7905,One sentence that said no unexpected adverse events were found so values are all 0 based on this.,TRUE,5143,4376,TEST,"[1695, 1100, 1245]","intervention:
  events: 6
  group_size: 6
comparator:
  events: 0
  group_size: 14


Confidence Interval (CI) for Comparison of Pharmacokinetics of Macitent
---
intervention:
  events: 3
  group_size: 6
comparator:
  events: 3
  group_size: 6

This YAML representation corresponds to the given information in the article, where the trial intervention
---
intervention:
    events: 4
    group_size: 6
comparator:
    events: 0
    group_size: 6


This contingency table contains the number of unexpected adverse events for macitentan doses
---
",True
541,7795,3508963,Baseline characteristics - history of first stone,Intravenous lidocaine,Intravenous morphine,binary,70,120,56,120,,,,,,,0.47000363,0.06776786,0.22314355,0.01547619,,TRUE,3561,2387,TEST,"[1353, 937]","intervention:
    events: 2
    group_size: 120

comparator:
    events: 2
    group_size: 120

baseline_characteristics:
     events: 2
    group_size
---
intervention:
  events: 108
  group_size: 45
comparator:
  events: 84
  group_size: 36

YAML:
<|assistant>
intervention:
  events: 105
---
",True
495,6488,5419060,Request-form errors: CHC A,Phlebotomy training programme,Control,binary,8,10218,11,7557,,,,,,,-0.6208037,0.21613955,-0.6201303,0.2156789,,TRUE,9292,5719,TEST,"[1697, 922, 1654, 1213]","intervention:
    events: 60
    group_size: 7
comparator:
    events: 45
    group_size: 9

Based on the information provided, there is no 2x2 contingency table in YAML
---
intervention:
    events: 60...79
    group_size: 7557...10218
comparator:
    events: 8...38
    group_size: 589...589

YAML:
intervention:
---
intervention:
    events: 17
    group_size: 15
comparator:
    events: 27
    group_size: 30

The YAML format below represents the contingency table for the given intervention, comparator, and
---
intervention:
    events: 55
    group_size: N/A      # Post-intervention, 55 blood samples rejected due to request form errors at CHC A
comparator:
    events: N/A
    group
---
",True
493,6484,5419060,Sample rejection rate: CDC C,Phlebotomy training programme,Control,binary,37,2279,38,2321,,,,,,,-0.0085462,0.05422687,-0.0084069,0.05247318,,TRUE,9292,5719,TEST,"[1697, 922, 1654, 1213]","intervention:
    events: 60
    group_size: 8

comparator:
    events: 45
    group_size: 10

<The YAML format above is missing the group_size value for the intervention
---
intervention:
  events: 10218
  group_size: 10218
comparator:
  events: 589
  group_size: 589

YAML:
<|assistant>
intervention:

---
intervention:
    events: 23
    group_size: 17

comparator:
    events: 19
    group_size: 20

outcome:
    CDC_C: 8 (0.20)
---
intervention:
    events: 55
    group_size: 8
comparator:
    events: 55
    group_size: 8

outcome:
    events: 4
    group_size: 5
st
---
",True
378,221,1475568,Baseline angiotensin-converting enzyme (ACE) inhibitors intake,Follow-up and thorough education on self-care,Standard information about self-care,binary,,59,,64,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,Unclear since the values for this are reported with ARB intake.,FALSE,4361,3649,TEST,"[1575, 980, 994]","intervention:
    events: 11
    group_size: 15

comparator:
    events: 9
    group_size: 15

outcome:
    events: 3
    group_size: 9
---
intervention:
  events: 60
  group_size: 39
comparator:
  events: 60
  group_size: 39

x: x
outcome: ACEIsintake
pre_intervention:

---
intervention:
    events: 24
    group_size: 8
HFQOL:
    events: 72
    group_size: 12
Angiotensin-converting enzyme (ACE) Intake:
    events: 39

---
",True
87,13569,3687098,The incidence of the composite endpoint of rash,sitagliptin 100 mg/day,comparator agent,binary,131,7726,76,6885,,,,,,,0.4352,0.0211,0.4292,0.0205,Used incidence rate per 100 to get the binary events.,TRUE,15196,10904,TEST,"[571, 1442, 1194, 1492, 1638, 1378, 1242, 1648]","intervention:
    events: 39
    group_size: 805
comparator:
    events: 12
    group_size: 427

This YAML represents the provided trial and the desired outcome, namely the incidence of
---
intervention:
  events: 11
  group_size: 678
comparator:
  events: 7
  group_size: 383

In the entire 25-study cohort, patients (55% male) had an
---
intervention:
  events: 15
  group_size: 500
comparator:
  events: 15
  group_size: 500

YAML:
 intervention:
   events: 10
   group_size:
---
intervention:
    events: 6
    group_size: N/A	
comparator:
    events: 2
    group_size: N/A
outcome:
    events: 1
    group_size
---
intervention:
    events: 5
    group_size: 592
comparator:
    events: 5
    group_size: 592

yamllint:
 allow-yn-attributes: true
---
intervention:
    events: 6
    group_size: 114
comparator:
    events: 10
    group_size: 318

YAML:
intervention:
    events: 3
    group_size:
---
intervention:
    events: 5
    group_size: 100
comparator:
    events: 5
    group_size: 100

YAML:
intervention:
    events: 10
    group_size:
---
intervention:
    events: 6
    group_size: 836
comparator:
    events: 6
    group_size: 836

YAML:
 intervention:
    events: 3
    group_
---
",True
340,11079,5655920,vomiting,Lixisenatide with moderate impairment,Lixisenatide with mild impairment,binary,,122,,637,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,placebo-adjusted meta-analysis (fixed effect) = 0.04,TRUE,13081,5825,TEST,"[804, 1270, 1096, 914, 1516]","intervention:
    events: 6
    group_size: 127
lixisenatide_mild:
    events: 123
    group_size: 316
lixisenatide_moderate:
    events: 122
---
intervention:
  events: 6
  group_size: 121
comparator:
  events: 3
  group_size: 43

vomiting:
  values:
  - ""0"" ""1""
---
intervention:
  events: 2
  group_size: 47
lixisenatide_mod_imp:
  events: 12
  group_size: 29
comparator:
  events: 15
  group
---
intervention:
    events: 2
    group_size: 39
comparator:
    events: 2
    group_size: 39

YAML:
intervention:
    events: 0
    group_size:
---
intervention:
    vomit: <number of events>
    group_size: <number of participants>

comparator:
    vomit: <number of events>
    group_size: <number of participants>
---
",True
20,3246,2972614,Adverse effects,Laser therapy (Group I),Placebo laser therapy (Group II),binary,0,30,0,22,,,,,,,-0.3042,4.0772,-0.2985,3.9243,,TRUE,7041,2968,TEST,"[1129, 1564]","intervention:
  events: 2
  group_size: 26
comparator:
  events: 2
  group_size: 26

YAML:
<|assistant>
intervention:
  events: 0
---
intervention:
    events: 3
    group_size: 11
comparator:
    events: 3
    group_size: 11

---
intervention:
    events: 0
    group_size: 7

---
",True
628,12233,3510731,Clicked on Protocol link,received the debriefing information in the body of an email with links to protocol and results pages;,received these links after clicking on an initial link in the body of the email to view the debriefing information on a website.,binary,202,6051,362,5892,,,,,,,-0.6394594,0.00806473,-0.6100046,0.00737794,found in table 1,TRUE,1665,1296,TEST,[],"intervention:
    events: 1048
    group_size: 1048
comparator:
    events: 1104
    group_size: 1104

Clicked on Protocol link: NUMBER x NUMBER
Click",False
361,8713,5971365,clinically meaningful worsening at week 96 (⩾3-point decrease on the SDMT),daclizumab beta,intramuscular (IM) interferon (IFN) beta-1a,binary,140,720,169,682,,,,,,,-0.311,0.0167,-0.2425,0.0102,"counts calculated from percentages given in text, totals found in figure",TRUE,3177,2394,TEST,"[539, 1511]","intervention:
    events: 12
    group_size: 492
comparator:
    events: 12
    group_size: 492

---

intervention:
    events: 91
    group_size: 362
---
intervention:
    events: 18
    group_size: 919
comparator:
    events: 18
    group_size: 922

YAML:
<intervention name=""daclizumab beta"">

---
",True
509,6486,5419060,Techinque related rejections: CDC C,Phlebotomy training programme,Control,binary,18,2279,15,2321,,,,,,,0.20202879,0.12309816,0.20058293,0.12135258,,TRUE,9292,5719,TEST,"[1697, 922, 1654, 1213]","intervention:
    events: 60
    group_size: 4

comparator:
    events: 45
    group_size: 4

</na>
Techinque related rejections: CDC C

post
---
intervention:
  events: 120
  group_size: 50
comparator:
  events: 120
  group_size: 50

techinque_related_rejections_CDC_C: x

FIG
---
intervention:
  events: 17
  group_size: 17
comparator:
  events: 10
  group_size: 10

yamllint enable: false --strict --validate-yamllist --
---
intervention:
     events: 55
    group_size: NUMBER
comparator:
    events: 55
    group_size: NUMBER

outcome:
    events: NUMBER
    group_size:
---
",True
272,2991,3214395,extremity movement,"group 1 included bispectral index (BIS) of 60, group 2 covered bispectral index (BIS) of 49",group 3 involved bispectral index (BIS) of 39,binary,16,60,9,30,,,,,,,-0.1643,0.244,-0.1178,0.1236,,TRUE,1201,996,TEST,[],"intervention:
    events: 2
    group_size: 20
comparator:
    events: 2
    group_size: 20

YAML:
intervention:
    events: 12
    group_size:",False
137,1267,4709985,would have liked more information on acupuncture,tertiary education,other educations,binary,,121,,89,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,Specific numbers were not given.,FALSE,3939,3288,TEST,"[442, 1456, 1278]","intervention:
    events: 113
    group_size: N/A
comparator:
    events: 107
    group_size: N/A

post_intervention:
    intervention: 91
    compar
---
intervention:
    events: 198
    group_size: 210
comparator:
    events: 178
    group_size: 210

YAML:
intervention:
    events: 49
    group_size:
---
intervention:
    events: 200
    group_size: 200
post_intervention:
    events: 162
    group_size: 162

comparator:
    events: 200
    group_size: 200

---
",True
474,5522,4144850,Independent household latrines number,Total Sanitation Campaign,Control,binary,673,1525,366,1514,,,,,,,0.90730205,0.00626291,0.60187274,0.00290188,Used percent to calculate outcomes for binary variables.,TRUE,24614,13328,TEST,"[887, 1114, 1560, 1599, 1396, 784, 1296, 1669, 298]","intervention:
    events: NUMBER_IMPROVED_SANITATION
    group_size: NUMBER

comparator:
    events: NUMBER_CONTROL
    group_size: NUMBER


---
intervention:
    events: 976 # Baseline (Intervention: Total Sanitation Campaign, Comparator: Control)
    group_size: N/A # Based on the base number of observations (N) for the reported percentages or the
---
intervention:
    events: 15
    group_size: Unknown
comparator:
    events: 1150
    group_size: Unknown

YAML:
<assistant→
intervention:
    events: 8
---
intervention:
    events: 2
    group_size: undefined

comparator:
    events: 2
    group_size: undefined

outcome:
    events: number_of_latrines
    
---
intervention:
    events: 2
    group_size: unknown
comparator:
    events: 2
    group_size: unknown

YAML:
<|assistant>
intervention:
    events: 12
---
intervention:
    events: NUMBER_OF_INTERVENTION_VILLAGES
    group_size: NUMBER_OF_HOUSEHOLDS_IN_INTERVENTION_VILLAGES

comparator:
---
intervention:
    events: 4
    group_size: unknown
comparator:
    events: 4
    group_size: unknown

YAML:
<|assistant>
intervention:
    events: 3
---
intervention:
    events: 2
    group_size: unknown

comparator:
    events: 2
    group_size: unknown

outcome:
    events: number_of_independent_latrines
---
intervention:
    events: NUMBER_OF_CHILDRENS_WITH_IMproved_Latrines
    group_size: NUMBER_OF_CHILDRENS_WITH_IMproved_Latrines


---
",True
477,5523,4144850,Open defecation - children,Total Sanitation Campaign,Control,binary,1279,1525,1350,1514,,,,,,,-0.4594912,0.0116852,-0.0612653,0.00020636,Used percent to calculate outcomes for binary variables.,TRUE,24614,13328,TEST,"[887, 1114, 1560, 1599, 1396, 784, 1296, 1669, 298]","intervention:
    events: 411
    group_size: 829
comparator:
    events: 444
    group_size: 921

YAML:
<intervene>
intervention:
    events
---
intervention:
  events: 976
  group_size: 976

comparator:
  events: 978
  group_size: 978

YAML:
<|assistant>
intervention:
  
---
intervention:
    events: 1
    group_size: 960
comparator:
    events: 1
    group_size: 960

YAML:
intervention:
    events: 8
    group_
---
intervention:
    events: 1020
    group_size: 14
comparator:
    events: 1020
    group_size: 14
outcome:
    events: 1126
    group_size: 12
---
intervention:
    events: 2
    group_size: 8
comparator:
    events: 2
    group_size: 8

YAML:
<intervention type=""Total Sanitation Campaign"" events=""2
---
intervention:
    events: NUMBER_OF_INTERVENTED_HOUSES
    group_size: NUMBER_OF_INTERVENTED_HOUSES

comparator:
    events: NUMBER_OF
---
intervention:
    events: 2
    group_size: 8

comparator:
    events: 2
    group_size: 8

< | ""list_tail"" |-- ""intervention"" />
< |
---
intervention:
    events: 10
    group_size: 10

comparator:
    events: 10
    group_size: 10

outcome:
    events: NUMBER_OF_CHILDRENS
---
intervention:
  events: NUMBER_OF_CHILDRENS_WITH_ANEMIA
  group_size: NUMBER_OF_CHILDRENS_WITH_ANEMIA

comparator:
  
---
",True
315,9842,4928400,Complication,Transperitoneal laparoscopic ureterolithotomy,Flexible ureteroscopy,binary,5,22,7,20,,,,,,,-0.6047,0.4786,-0.4318,0.2474,,TRUE,4037,2288,TEST,"[411, 1658]","intervention:
    complication_rate: 10 # post-intervention (out of 42)
    group_size: 42 # post-intervention
comparator:
    complication_rate: 5 # post-intervention (out of
---
intervention:
    events: 22
    group_size: 20
comparator:
    events: 20
    group_size: 20
---
outcome:
    events: 8
    group_size: 8

---
",True
333,5080,5617873,Serious adverse effects,Aripiprazole,Placbeo,binary,0,45,3,47,,,,,,,-1.9681,2.3302,-1.9034,2.2431,all means and std found in table 2,TRUE,7551,5383,TEST,"[1415, 890, 1516, 1220]","intervention:
    events: 9
    group_size: 47
comparator:
    events: 4
    group_size: 47

YAML:
intervention:
    events: 3
    group_size:
---
intervention:
  events: 47
  group_size: 48

comparator:
  events: 47
  group_size: 48

outcome:
  events: 0
  group_size: 48
---
intervention:
    events: 10
    group_size: 13
comparator:
    events: 7
    group_size: 9


Note: This is just a sample YAML format based on the given information.
---
intervention:
    events: 39
    group_size: 47
comparator:
    events: 33
    group_size: 45


# Alternative option

intervention:
    events: 39
    group_
---
",True
400,2243,4678179,rate of adverse events,vismodegib plus gemcitabine (GV),gemcitabine plus placebo (GP),binary,4,53,2,53,,,,,,,0.73315252,0.79001601,0.69314718,0.71226415,Used numbers found in results section text.,TRUE,9517,6474,TEST,"[587, 1390, 1376, 1423, 903]","intervention:
    events: 106
    group_size: 53
vismodegib:
    events: 42
    group_size: 42
gemcitabine:
    events: 158
    group_size: 158
---
intervention:
    events: 106
    group_size: 53

comparator:
    events: 106
    group_size: 53

yaml_output:
intervention:
  events: 106
  
---
intervention:
    events: 46
    group_size: 53
comparator:
    events: 46
    group_size: 53

YAML:
intervention:
    events: 30
    group_size:
---
intervention:
    events: 87
    group_size: 39
comparator:
    events: 89
    group_size: 40

YAML:
intervention:
    events: 44
    group_size
---
intervention:
    events: 2
    group_size: 24
comparator:
    events: 2
    group_size: 24

YAML:
intervention:
    events: 6
    group_size:
---
",True
122,7936,4486927,The early virologic response (EVR),peginterferon (Peg-IFN) plus ribavirin (RBV) for 48 weeks,peginterferon (Peg-IFN) plus ribavirin (RBV) for 24 weeks,binary,86,94,82,93,,,,,,,0.3661,0.2397,0.0369,0.0024,,TRUE,14472,7883,TEST,"[1552, 1355, 924, 953, 1012, 944, 1127]","intervention:
    EVR: NUMBER
    group_size: NUMBER	
comparator:
    EVR: NUMBER
    group_size: NUMBER

YAML:
<intervention:
    
---
intervention:
    EVR: NUMBER
    group_size: NUMBER
comparator:
    EVR: NUMBER
    group_size: NUMBER

YAML:
 intervention:
    EVR_
---
intervention:
    EVR: 94
    number: 94

comparator:
    EVR: 88.3
    number: 93

<Code note>
This YAML format is the one for the provided table
---
intervention:
    EVR: 68/84 (84.2%)
comparator:
    EVR: 72/84 (87.5%)

This YAML represents the contingency table you requested: a 2x2 table
---
intervention:
  events: 84
  group_size: 87
comparator:
  events: 84
  group_size: 87

YAML:
<assistant>,EVR_rate:%EVR_48
---
intervention:
    EVR: 54
    number: 94

comparator:
    EVR: 48
    number: 93

The YAML format above represents the requested contingency table. The ""EVR"" column for
---
intervention:
    EVR: 78
    number: 94
group_size: 2

comparator:
    EVR: 74
    number: 93
group_size: 2

This YAML shows that 78
---
",True
654,13101,5976307,The incidence rate of myoclonus,etomidate,propofol based on midazolam,binary,10,62,1,62,,,,,,,2.46221524,1.13562421,2.30258509,1.06774194,found in table 3,TRUE,2560,2044,TEST,"[525, 1303]","intervention:
    events: 17
    group_size: 30
etomidate:
    events: 31
    group_size: 42

comparator:
    events: 50
    group_size: 70
---
intervention:
    events: 72
    group_size: 57
etomidate:
    events: 65
    group_size: 51
myoclonus:
    post: 50...1...x
    pre
---
",True
40,6985,3169777,unexpected adverse events,macitentan doses of 25 mg,placebo,binary,0,6,0,14,,,,,,,0.8023,4.2228,0.7621,3.7905,One sentence that said no unexpected adverse events were found so values are all 0 based on this.,TRUE,5143,4376,TEST,"[1695, 1100, 1245]","intervention:
    events: 3
    group_size: 6
comparator:
    events: 3
    group_size: 6

---

intervention:
    events_post: 3
    group_size
---
intervention:
    events: 3
    group_size: 6
comparator:
    events: 3
    group_size: 6

YAML:
<intervention name=""macitentan 25 mg"" events
---
intervention:
    events: 3
    group_size: 6
comparator:
    events: 0
    group_size: 6


This YAML format is created based on the given information. The contingency table represented
---
",True
139,3100,4830045,Embryo quality,Patients in the 3h group,Patients in the 20h group,binary,,74,,60,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,Unclear outcome measures.,FALSE,2530,2096,TEST,"[418, 1588]","intervention:
  events: 134
  group_size: 73

comparator:
  events: 54
  group_size: 30

YAML:
intervention:
  events: 87
  group_size
---
intervention:
  events: 134
  group_size: 2
comparator:
  events: 60
  group_size: 2

YAML:
<|assistant>
intervention:
  events: 149
---
",True
484,5713,3343759,history of myocardial infarction,very early speech and language therapy (SLT),control,binary,,,,,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,Numerical data are only in methods section.,FALSE,3838,2633,TEST,"[1682, 865]","intervention:
    events: 114
    group_size: 117

comparator:
    events: 123
    group_size: 125

outcome:
    events: x
    group_size: x
---
intervention:
    events: 14
    group_size: 59
comparator:
    events: 55
    group_size: 55

YAML:
<intervention name=""very early speech and language therapy (SL
---
",True
496,6488,5419060,Request-form errors: CHC B,Phlebotomy training programme,Control,binary,12,4114,11,3973,,,,,,,0.05228567,0.17473861,0.05213706,0.17374765,,TRUE,9292,5719,TEST,"[1697, 922, 1654, 1213]","intervention:
  events: 23
  group_size: 4

comparator:
  events: 23
  group_size: 4

outcome:
  events: 13
  group_size: 3
---
intervention:
    events: 60
    group_size: 7557

comparator:
    events: 8
    group_size: 3973

request-form errors: CHC B post-intervention
group_
---
intervention:
    requests:
        - Technique related: x
        - Clotted: x
        - Haemolysed: x
        - Knowledge related: x
        - Request form errors: x
        - No
---
intervention:
  events: 55
  group_size: 59
comparator:
  events: 55
  group_size: 59

outcome:
  requests:
    - group_name: CHC B
---
",True
94,10167,4173437,Adverse effects,Tranexamic acid,Control,binary,0,30,0,30,,,,,,,0,4.0656,0,3.9355,Had to infer that the group sizes were equal.,TRUE,854,745,TEST,[],"intervention:
  events: 6
  group_size: 30
comparator:
  events: 6
  group_size: 30

YAML:
<|assistant>
intervention:
  events: 4",False
482,5524,4144850,E. coli contaminated water,Total Sanitation Campaign,Control,binary,310,404,331,403,,,,,,,-0.3321747,0.03077414,-0.0680244,0.00129032,Used percent to calculate outcomes for binary variables.,TRUE,24614,13328,TEST,"[887, 1114, 1560, 1599, 1396, 784, 1296, 1669, 298]","intervention:
  events: 214
  group_size: 925
comparator:
  events: 213
  group_size: 930

X: E. coli contaminated water
Post-intervention: 87 (1
---
intervention:
    events: 976
    group_size: 978

comparator:
    events: 978
    group_size: 978

<|assistant>
YAML:
intervention:
    events
---
intervention:
    events: 1
    group_size: N/A # Post-intervention data
comparator:
    events: 1
    group_size: N/A # Post-intervention data

outcome:
---
intervention:
    events: 1
    group_size: 113
E. coli contaminated water:
    intervention: <21>
        events: <21>
            <81>: 11
        group_size: <21>
---
intervention:
    events: 619
    group_size: 12
comparator:
    events: N/A
    group_size: N/A
E. coli contaminated water:
    intervention: 405
    
---
intervention:
    events: 630
    group_size: 430
post_intervention:
    intervention: 402
    comparator: 401

YAML:
intervention:
    events: 491
    group_size:
---
intervention:
  events: 122
  group_size: 44
comparator:
  events: 114
  group_size: 44

YAML:
<assistant>:
intervention:
  events: 52

---
intervention:
    events: 792
    group_size: 28
comparator:
    events: 786
    group_size: 28

 YAML:
 intervention:
    events: 792
    group
---
intervention:
    events: 123
    group_size: 247

comparator:
    events: 123
    group_size: 247

eoutcome:
    events: 139
    group_size: 238
---
",True
41,6985,3169777,unexpected adverse events,macitentan doses of 100 mg,placebo,binary,0,6,0,14,,,,,,,0.8023,4.2228,0.7621,3.7905,One sentence that said no unexpected adverse events were found so values are all 0 based on this.,TRUE,5143,4376,TEST,"[1695, 1100, 1245]","intervention:
  events: 6
  group_size: 6
comparator:
  events: 6
  group_size: 6

yamllint:
 enable-linter: my-specific-lint-
---
intervention:
    events: 2
    group_size: 15
comparator:
    events: 2
    group_size: 15

YAML:
<interventions>
  macitentan_100:
---
intervention:
  events: 7
  group_size: 6
comparator:
  events: 3
  group_size: 6

# For the outcome of ""unexpected adverse events"" and the timeframe closest to
---
",True
259,10575,5711682,rates of death,Genoss drug-eluting stent (DES),Promus Element,binary,1,38,0,39,,,,,,,1.1506,2.7186,1.1239,2.616,,TRUE,13148,4660,TEST,"[1216, 1005, 1468, 949]","intervention:
    events: 12
    group_size: 39
comparator:
    events: 11
    group_size: 39

YAML:
<assistant>:
 intervention:
    events: 6

---
intervention:
    events: 3
    group_size: 844
comparator:
    events: 120
    group_size: 396

YAML:
<intervention:
  events: 14
  group
---
intervention:
    events: 2
    group_size: 338

comparator:
    events: 2
    group_size: 338

The response provided is:
intervention:
    events: 8
    group
---
intervention:
    events: 4
    group_size: 21
comparator:
    events: 4
    group_size: 21

YAML:
<intervention name=""Genoss DES"" >
  <
---
",True
344,11082,5655920,Hypoglycaemia,Lixisenatide with moderate impairment,Lixisenatide with mild impairment,binary,,122,,637,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,placebo-adjusted meta-analysis (fixed effect) = 0.04,TRUE,13081,5825,TEST,"[804, 1270, 1096, 914, 1516]","intervention:
    events: 5
    group_size: 140
comparator:
    events: 10
    group_size: 130

----

intervention:
    events: 29
    group_size: 67
---
intervention:
  events: 35
  group_size: 128

comparator:
  events: 20
  group_size: 88

outcome:
  events: 8
  group_size: 42
---
intervention:
  events: 2
  group_size: 52
comparator:
  events: 2
  group_size: n/a

This YAML format does not provide information about the frequency or odds ratio of
---
intervention:
    events: 2
    group_size: 28
comparator:
    events: 2
    group_size: 28

YAML:
intervention:
    events: 10
    group_size:
---
intervention:
    events: 2
    group_size: 118
comparator:
    events: 2
    group_size: 123

YAML:
<|assistant>
intervention:
    events: 6
---
",True
362,8714,5971365,clinically meaningful improvement at week 96 (⩾3-point increase on the SDMT),daclizumab beta,intramuscular (IM) interferon (IFN) beta-1a,binary,432,720,369,682,,,,,,,0.2409,0.0117,0.1034,0.0022,"counts calculated from percentages given in text, totals found in figure",TRUE,3177,2394,TEST,"[539, 1511]","intervention:
    events: 921
    group_size: 918
comparator:
    events: 922
    group_size: 922

---

intervention:
    events: 921
    group_
---
intervention:
    events: 19
    group_size: 919
comparator:
    events: 922
    group_size: 922

YAML:
<assistant>:
intervention:
    events
---
",True
65,1644,3309311,The proportion of HIZ incidence,"adults with acute axial severe LBP who could not sit up or stand up for several days, but had not experienced previous back-related diseases or trauma (group A)",adults with LBP with radicular pain (group C),binary,14,23,3,18,,,,,,,2.0513,0.5825,1.2953,0.3057,Used percentage to calculate events as binary outcome.,TRUE,1437,1263,TEST,[],"intervention:
    events: 23
    group_size: 1

comparator:
    events: 19
    group_size: 1

YAML:
intervention:
    events: 23
    group_size",False
377,222,1475568,Baseline digoxin intake,Follow-up and thorough education on self-care,Standard information about self-care,binary,15,59,12,64,,,,,,,0.3902,0.192,0.3045,0.1174,Used percentage found in table to calculate actual number for binary variable.,TRUE,4361,3649,TEST,"[1575, 980, 994]","intervention:
  events: 11
  group_size: 19

comparator:
  events: 11
  group_size: 19

outcome:
  baseline digoxin intake:
    events: 4

---
intervention:
    events: 13
    group_size: 59

comparator:
    events: 64
    group_size: 59

digoxin:
    post: 11.1
    pre: 10.
---
intervention:
  events: 24
  group_size: 24
comparator:
  events: 24
  group_size: 24

YAML:
intervention:
  events: 47
  group_size:
---
",True
626,11906,3493722,poor compliance rates,1-week quadruple rescue therapy,2-week quadruple rescue therapy,binary,2,81,3,81,,,,,,,-0.4182041,0.85881207,-0.4054651,0.80864198,"found in table 2, assumed binary because proportion of whole given",TRUE,1684,1549,TEST,[],"intervention:
  events: 85
  group_size: 86
comparator:
  events: 84
  group_size: 85

YAML:
<|assistant>
intervention:
  events: 72",False
691,13831,4210722,use of a reminder card,a separate reminder card 4 days before the appointment (IG3); reminder card together with the appointment letter (IG2);,no further reminder (IG1),binary,185,209,84,104,,,,,,,0.60721747,0.10897683,0.09159567,0.00291009,found in text as fractions of group sizes,TRUE,10493,8112,TEST,"[915, 1629, 366, 1445, 843, 1539, 1164]","intervention:
    events: 188
    group_size: 109
  
comparator:
    events: 148
    group_size: 81
<|assistant>
YAML:
 intervention:
    events:
---
intervention:
    events: 209
    group_size: 209

comparator:
    events: 209
    group_size: 209

outcome:
    use:
        events: 193
        group_
---
intervention:
  events: NUM_Vacc_Certs_Captured_Electronicly
  group_size: NUM_Vacc_Certs_Captured_Electronicly
Vaccation:
  events: NUM_V
---
intervention:
    events: 2
    group_size: 2

comparator:
    events: 2
    group_size: 2

outcome:
    use of a reminder card: 2
    x:
---
intervention:
    events: 2
    group_size: 2
post_intervention:
    events: 28
    group_size: 28

Explanation:

Based on the provided information in the text, the data collected
---
intervention:
    events: 11
    group_size: 118
intervention_post:
    events: 10
    group_size: 101
comparator:
    events: 101
    group_size: 118

---
intervention:
    events: 2
    group_size: 150
  
comparator:
    events: 2
    group_size: 150

outcome:
    use:
        events: 138
        group
---
",True
342,11080,5655920,vomiting,Lixisenatide with moderate impairment,Lixisenatide with normal renal function,binary,,122,,2094,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,placebo-adjusted meta-analysis (fixed effect) = -0.03,TRUE,13081,5825,TEST,"[804, 1270, 1096, 914, 1516]","intervention:
  vomiting: 5
  group_size: N/A
comparator:
  vomiting: 4
  group_size: N/A

YAML:
<|assistant>:
---
intervention:
  events: 17
  group_size: 285
comparator:
  events: 11
  group_size: 283

YAML:
<|assistant>
intervention:
  events: 5
---
intervention:
  events: 2
  group_size: 26
comparator:
  events: 2
  group_size: 26

x vv vomiting x xx 0.8
vv vv vomiting x xx 0
---
intervention:
  events: 2
  group_size: 24
comparator:
  events: 2
  group_size: 24

YAML:
intervention:
  events: 0
  group_size:
---
intervention:
  events: 14
  group_size: 14
comparator:
  events: 14
  group_size: 14

YAML:
<|assistant>
intervention:
  events: 4
---
",True
625,11906,3493722,well compliance rates,1-week quadruple rescue therapy,2-week quadruple rescue therapy,binary,8,81,4,81,,,,,,,0.74649316,0.40168564,0.69314718,0.35030864,"found in table 2, assumed binary because proportion of whole given",TRUE,1684,1549,TEST,[],"intervention:
    events: 85
    group_size: 85
comparator:
    events: 84
    group_size: 84

YAML:
<|assistant>:
intervention:
    events: 72",False
124,7937,4486927,The SVR rates when the patients had BMI >30 kg/m2,peginterferon (Peg-IFN) plus ribavirin (RBV) for 48 weeks,peginterferon (Peg-IFN) plus ribavirin (RBV) for 24 weeks,binary,10,19,6,12,,,,,,,0.1054,0.5444,0.0513,0.1307,"Even though the outcome says rate, the way that the results are reported in the table makes it easier to calculate as binary outcome.",TRUE,14472,7883,TEST,"[1552, 1355, 924, 953, 1012, 944, 1127]","intervention:
    events: 94
    group_size: 231
comparator:
    events: 93
    group_size: 230

YAML:
<intervention name=""peginterferon (Peg-
---
intervention:
    events: 48
    group_size: N/A
comparator:
    events: 90
    group_size: N/A

YAML:
<assistant>:
events: 118

---
intervention:
    events: 24...94
    group_size: 44
comparator:
    events: 9...94
    group_size: 44
---
comparator:
    events: 3...93

---
intervention:
    events: 35
    group_size: 33
comparator:
    events: 61
    group_size: 61

 YAML:
<assistant>:
events: 34
group_size:
---
intervention:
    events: 38
    group_size: 54
comparator:
    events: 39
    group_size: 52

This 2x2 contingency table shows the number of patients with BMI >30 kg/
---
intervention:
    events: 12
    group_size: 94
comparator:
    events: 12
    group_size: 93

YAML:
<assistant>:
events: 6
group_size:
---
intervention:
    events: 12
    group_size: 130
comparator:
    events: 12
    group_size: 130

This is the YAML contingency table you requested:

| Outcome            |
---
",True
546,8461,3263860,Severe hypoglycemia,Real-Time Continuous Glucose Monitoring,Control,binary,3,73,5,71,,,,,,,-0.5696661,0.56277056,-0.5386052,0.5055502,,TRUE,3178,2587,TEST,"[1296, 936]","intervention:
    events: 3
    group_size: 142

comparator:
    events: 8
    group_size: 67

< YAML format for the provided article data is:

intervention:

---
intervention:
    events: 63...91%
    group_size: n_total

comparator:
    events: n_total
    group_size: n_total

YAML:
 intervention:

---
",True
343,11081,5655920,Hypoglycaemia,Lixisenatide with normal renal function,Lixisenatide with mild impairment,binary,,2094,,637,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,placebo-adjusted meta-analysis (fixed effect) = -0.02,TRUE,13081,5825,TEST,"[804, 1270, 1096, 914, 1516]","intervention:
    events: 13 22
    group_size: 53
lixisenatide_nonalowren:
    events: 8 14
    group_size: 30
comparator:
    events: 23
---
intervention:
    events: 11
    group_size: 623
comparator:
    events: 61
    group_size: 281

YAML:
<|assistant>
intervention:
    events:
---
intervention:
  events: 2
  group_size: 44
lixisenatide_normal:
  events: 22
  group_size: 44
comparator:
  events: 23
  group_size
---
intervention:
  events: 2
  group_size: 58
Lixisenatide with normal renal function:
  events: 58
  group_size: 58
Comparator:
  events: 58
  group
---
intervention:
    events: 2
    group_size: 30
comparator:
    events: 2
    group_size: 30

YAML:
intervention:
    events: 10
    group_size:
---
",True
631,12275,3936115,The number of diverticulitis clinical symptom occurrences during 12months,Microencapsulated sodium butyrate (MSB) 300 mg daily,control group was administered placebo,binary,2,30,7,22,,,,,,,-1.8769173,0.7452381,-1.5629179,0.56406926,found in table 1,TRUE,2217,2016,TEST,"[352, 1494]","intervention:
  events: 52
  group_size: 29

comparator:
  events: 22
  group_size: 11

< YAML error: Missing required key/value pair ""outcome"".

---
intervention:
  events: NUMBER_OF_DIFFERENT_CLINICAL_SYMPTOMS_IN_12_MONTHS
  group_size: NUMBER_OF_PARTICIPANTS_
---
",True
127,4924,4493951,the incidence of postoperative nausea and vomiting (PONV),H1(haloperidol 1 mg),H0 (saline),binary,11,49,21,50,,,,,,,-0.9169,0.1993,-0.6264,0.0981,Used numbers from Late time (2–24 h),TRUE,3932,3205,TEST,"[1642, 1336]","intervention:
    events: 154
    group_size: 50

comparator:
    events: 105
    group_size: 35

<Based on the information provided in the article, the 2x2 contingency table
---
intervention:
  events: NUM_H1
  group_size: N_H1

comparator:
  events: NUM_S
  group_size: N_S

< noinput >
The
---
",True
13,12633,2667135,proportion of patients completed therapy,some portion of therapy outside of the hospital (CoPAT),full course of therapy in the hospital setting,binary,93,103,44,97,,,,,,,2.4161,0.1523,0.6884,0.0135,,TRUE,11722,8106,TEST,"[785, 1636, 1388, 1684, 826, 1109]","intervention:
    events: 195
    group_size: 200
post_intervention:
    events: 163
    group_size: 200

YAML:
<assistant>>
intervention:
    events: 94

---
intervention:
    events: 91
    group_size: 108

comparator:
    events: 95
    group_size: 115

outcome:
    events:
        completion: 86%

This
---
intervention:
  events: 50
  group_size: 50
coPAT:
  events: 50
  group_size: 50
completed_therapy:
  events: n(CoPAT) * (n(Co
---
intervention:
    events: 50
    group_size: 30

comparator:
    events: 50
    group_size: 30

outcome:
    proportion_completed_therapy: 50

<
---
intervention:
    events: 103
    group_size: 97
post_intervention:
    events: 83
    group_size: 85

Explanation:
The contingency table provided in the Table-wrap shows the proportions of
---
intervention:
    events: 43
    group_size: 50
post_intervention:
    events: 26
    group_size: 29

Explanation: 
The provided data indicates 43 patients in the CoPAT group and
---
",True
269,2991,3214395,laryngospasm,"group 1 included bispectral index (BIS) of 60, group 2 covered bispectral index (BIS) of 46",group 3 involved bispectral index (BIS) of 36,binary,11,60,3,30,,,,,,,0.7033,0.4817,0.6061,0.3742,,TRUE,1201,996,TEST,[],"intervention:
    events: 2
    group_size: 26
comparator:
    events: 8
    group_size: 13

Table-1:
- laryngospasm: 3
- laryngosp",False
478,5525,4144850,Helminth infections,Total Sanitation Campaign,Control,binary,34,581,32,569,,,,,,,0.04217391,0.06435212,0.0397543,0.05718313,Used percent to calculate outcomes for binary variables.,TRUE,24614,13328,TEST,"[887, 1114, 1560, 1599, 1396, 784, 1296, 1669, 298]","intervention:
    events: 23
    group_size: 806
comparator:
    events: 962
    group_size: 2,919

Helminth infections:
    intervention: <post-
---
intervention:
    events: 969...978
    group_size: 969...978

comparator:
    events: 972...985
    group_size: 972...985

<Your
---
intervention:
    events: 975
    group_size: 1
comparator:
    events: 1,082
    group_size: 1

outcome:
    events: 172
    group_size:
---
intervention:
    events: 899
    group_size: 1739
comparator:
    events: 1092
    group_size: 1030

Helminth infections:
    events: 566
    
---
intervention:
  events: 1250
  group_size: unknown
comparator:
  events: 1250
  group_size: unknown

outcome:
  helminth_infections: 960

---
intervention:
    events: 630
    group_size: 370
intervention_post:
    events: 630
    group_size: 370
    helminth_infections:
        ANY NAMED TYSR
---
intervention:
    events: 1147
    group_size: 1036
helminth infections:
    intervention: 732
    comparator: 710
---
title: ""Effect of the intervention on health outcomes""

---
intervention:
  events: 2
  group_size: 2
comparator:
  events: 2
  group_size: 2

 Helminth infections:
  events: 6
  group_size: 6
---
intervention:
    events: 134
    group_size: 2

comparator:
    events: 110
    group_size: 2

y: "" 134 x 2 = 270""
---
",True
178,10755,5086025,Binge eating,Intuitive Eating and Acceptance and Commitment Therapy,Control,binary,7,26,14,26,,,,,,,-1.1527,0.3503,-0.6931,0.1374,,TRUE,29049,17627,TEST,"[767, 1239, 1629, 1656, 1592, 456, 1628, 806, 1676, 979, 1227, 1343]","intervention:
  events: 17
  group_size: 12

comparator:
  events: 17
  group_size: 12

outcome:
  events: 9
  group_size: 9

---
intervention:
    events: 12
    group_size: 12

comparator:
    events: 9
    group_size: 9

Binge eating:
    post: 6
    x: 0.5
---
intervention:
  events: 22
  group_size: 13

comparator:
  events: 22
  group_size: 13

outcome:
  events: 11
  group_size: 9

---
intervention:
  events: 14
  group_size: 10

comparator:
  events: 14
  group_size: 10

outcome:
  events: 7
  group_size: 7

---
intervention:
    events: 12
    group_size: 25

comparator:
    events: 26
    group_size: 26

outcome:
     events: 11
    group_size: 13

---
intervention:
    events: 47
    group_size: 12
intuitive_eating:
    events: n/a
    group_size: n/a
comparator:
    events: 47
    group
---
intervention:
    events: 2
    group_size: 12

comparator:
    events: 1
    group_size: 8

mMissing: x
nMissing: x

aBinge:
---
intervention:
    events: 14
    group_size: 12
binge_ eating:
    events: 4... x

COMMENT: The provided data only provides information on the proportion of participants who reported binge eating at the
---
intervention:
    events: 12
    group_size: 12

comparator:
    events: 8
    group_size: 8

binge_pre: x
binge_post: 11

Please
---
intervention:
  events: 14
  group_size: 8

comparator:
  events: 14
  group_size: 8

outcome:
  binge_episodes:
    events:
---
intervention:
    events: 3
    group_size: 12

comparator:
    events: 9
    group_size: 8

Binge eating:
    intervention:
        events: 25
        group
---
intervention:
    events: 3
    group_size: 8

comparator:
    events: 3
    group_size: 8

outcome:
    Binge_Eating:
        events: 20
---
",True
405,2807,5781260,adverse events,lemon verbena extract,placebo,binary,,20,,20,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,Unclear numerical values.,FALSE,4385,3505,TEST,"[469, 1412, 1359]","intervention:
    events: 6
    group_size: 23

comparator:
    events: 6
    group_size: 23

outcome: adverse events

Post-intervention data
YAML:

---
intervention:
    events: 3
    group_size: 40
comparator:
    events: 3
    group_size: 40

YAML:
intervention:
    events: 7
    group_size:
---
intervention:
    events: 8
    group_size: 8
comparator:
    events: 8
    group_size: 8

# If the outcome is ""adverse events"", select the post-intervention data

---
",True
641,12879,5830087,objective response rate (ORR),"BTH1677 arm ( intravenous [IV] BTH1677, 4 mg/kg, weekly; IV bevacizumab, 15 mg/kg, once each 3-week cycle [Q3W]; IV carboplatin, 6 mg/mL/min Calvert formula area-under-the-curve, Q3W; and IV paclitaxel, 200 mg/m2, Q3W)",Control arm ( bevacizumab/carboplatin/paclitaxel as above),binary,29,48,19,23,,,,,,,-1.1352878,0.38974592,-0.3128499,0.02280274,found in table 2,TRUE,11942,10628,TEST,"[587, 1574, 1647, 1581, 1512, 1605, 1190]"," intervention:
    events: 61
    group_size: 31
 post_intervention:
    events: 60.4
    group_size: 31

or


YAML:
<|assistant>,

---
intervention:
    events: 50
    group_size: 2

comparator:
    events: 50
    group_size: 2

outcome:
    ORR:
        events: 50
Post-
---
intervention:
    ORR: 3
    group_size: N/A
comparator:
    ORR: 1
    group_size: N/A

This YAML format represents a 2x2 contingency table
---
intervention:
    ORR: 14 (71.4%)
    group_size: N/A

comparator:
    ORR: 11 (57.1%)
    group_size: N/A


---
intervention:
    ORR: 12 (75.0%)
comparator:
    ORR: 6 (37.5%)

Note: ORR for the intervention arm (BTH1677) post-treatment is 75
---
intervention:
    ORR: 14/59 (22.4%)
    group_size: N/A

comparator:
    ORR: 8/30 (25.0%)
    group_size: N
---
intervention:
    ORR: NUMBER # lacking data in provided article, assuming 100% for both arms due to absence of pre and post-intervention data for this outcome
comparator:
    ORR: NUMBER # assuming 100
---
",True
153,13479,5055753,The percentages of patients in the sedated scale,0.2 mg oral clonidine,2 mg oral midazolam,binary,17,40,7,40,,,,,,,1.2483,0.2755,0.8873,0.1517,"Even though the outcome says percentage, the way that the results are reported in the table makes it easier to calculate as binary outcome.",TRUE,3292,2470,TEST,"[1695, 567]","intervention:
    events: 40
    group_size: 8

comparator:
    events: 40
    group_size: 8

outcome:
    events: NUMBER
    group_size: NUM
---
intervention:
  events: 2
  group_size: 26
comparator:
  events: 2
  group_size: 13

YAML:
intervention:
  events: 13
  group_size:
---
",True
542,7795,3508963,Baseline characteristics - right kidney stone,Intravenous lidocaine,Intravenous morphine,binary,60,120,57,120,,,,,,,0.10008346,0.06675021,0.05129329,0.01754386,,TRUE,3561,2387,TEST,"[1353, 937]","intervention:
  events: 2
  group_size: 120
comparator:
  events: 2
  group_size: 120

YAML:
intervention:
  events: 2
  group_size:
---
intervention:
  events: 109
  group_size: 108
comparator:
  events: 84
  group_size: 84

YAML:
<|assistant>
intervention:
  events: 29
---
",True
689,13830,4210722,vaccination certificates were submitted,a separate reminder card 4 days before the appointment (IG3),no further reminder (IG1),binary,94,102,84,104,,,,,,,1.02876872,0.19754306,0.13189607,0.00312375,found in text as fractions of group sizes,TRUE,10493,8112,TEST,"[915, 1629, 366, 1445, 843, 1539, 1164]","intervention:
    events: 179
    group_size: 209
post_intervention:
    events: 163
    group_size: 209

This contingency table represents the relationship between the two interventions (IG3 vs. IG1
---
intervention:
  events: 173
  group_size: 146
comparator:
  events: 166
  group_size: 135

YAML:
<|assistant>
intervention:
  events: 117
---
intervention:
    events: 370
    group_size: 450
comparator:
    events: 350
    group_size: 450

YAML:
intervention:
    events: 340 # post-intervention (372
---
intervention:
  events: 2
  group_size: 2

comparator:
  events: 2
  group_size: 2

outcome:
  events: 138
  group_size: 138

---
intervention:
    events: 6
    group_size: 8
comparator:
    events: 6
    group_size: 8

YAML:
<intervention name=""IG3"">
  <events>
---
intervention:
    events: 6
    group_size: 150
comparator:
    events: 150
    group_size: 150

YAML:
intervention:
    events: 4
    group_size:
---
intervention:
    events: 3
    group_size: 187

comparator:
    events: 187
    group_size: 187

outcome:
    events: 187
    group_size: 187

---
",True
501,6489,5419060,Preanalytical errors: CDC C,Phlebotomy training programme,Control,binary,10,2279,15,2321,,,,,,,-0.3892899,0.16754104,-0.3872037,0.16579703,,TRUE,9292,5719,TEST,"[1697, 922, 1654, 1213]","intervention:
    events: 60
    group_size: 23

comparator:
    events: 60
    group_size: 23

CDC_C_pre: x
CDC_C_post: x

---
intervention:
    events: 10218
    group_size: 10218
comparator:
    events: 589
    group_size: 589

YAML:
intervention:
    events: 630
    
---
intervention:
    events: 27
    group_size: 50
comparator:
    events: 16
    group_size: 40

YAML:
 intervention:
    events: 23
    group_size:
---
intervention:
    events: 55
    group_size: N/A
comparator:
    events: N/A
    group_size: N/A
outcome:
    CDC_C: 11
groups
---
",True
250,12425,5614421,The incidence of respiratory distress syndrome,vaginal progesterone pessaries (equivalent to 100 mg vaginal progesterone),placebo,binary,42,402,41,388,,,,,,,-0.0127,0.0539,-0.0113,0.0431,,TRUE,25930,11480,TEST,"[944, 1698, 158, 1679, 998]","intervention:
    events: 10...15
    group_size: 787

comparator:
    events: 38...42
    group_size: 389

This contingency table represents the incidence of respiratory distress syndrome in
---
intervention:
    events: 41
    group_size: 89
comparator:
    events: 35
    group_size: 86

Respiratory distress syndrome (RDS) is rare in this trial, and the data
---
intervention:
    events: 10.5%
    group_size: 402
comparator:
    events: 10.6%
    group_size: 388

YAML:
<|assistant>
intervention
---
intervention:
  events: 406
  group_size: 402
comparator:
  events: 393
  group_size: 388

YAML:
  intervention:
    events: 364
    group_size
---
intervention:
    events: 8
    group_size: 237

comparator:
    events: 8
    group_size: 237

outcome:
    events: 13
    group_size: 237
---
",True
174,2796,5079604,The probability of relapse,"metformin 1,000 mg daily, sitagliptin 100 mg daily",placebo,binary,9,33,11,15,,,,,,,-1.9924,0.4937,-0.9891,0.1051,Used percentage to calculate events as binary outcome.,TRUE,12690,6902,TEST,"[767, 1239, 1629, 1656, 890]","intervention:
    events: 2... 4
    group_size: 48

comparator:
    events: 2... 4
    group_size: 48

YAML:
intervention:
    events: 0...
---
intervention:
  events: 7
  group_size: 10
comparator:
  events: 5
  group_size: 10

YAML:
<interventions>
  ""metformin"": {
    
---
intervention:
    events: 6
    group_size: 28
comparator:
    events: 6
    group_size: 28

YAML:
interventions:
- metformin 1000 mg daily
- sitag
---
intervention:
  events: 21
  group_size: 35
sitagliptin:
  events: 21
  group_size: 35
  
comparator:
  events: 28
  group_size:
---
intervention:
    events: 13
    group_size: 29
comparator:
    events: 13
    group_size: 29

yaml_data: &yaml_data
  post_metformin:
---
",True
64,1642,3309311,differences in the HIZ,"adults with acute axial severe LBP who could not sit up or stand up for several days, but had not experienced previous back-related diseases or trauma (group A)","adults who had been involved in a minor traffic accident, and had mild symptoms but not limited mobility (group B)",binary,,23,,19,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,Data is in graphic table.,TRUE,1437,1263,TEST,[],"intervention:
    events: 23
    group_size: 1

comparator:
    events: 19
    group_size: 1

YAML:
 intervention:
    events: 18
    group_size",False
37,6985,3169777,unexpected adverse events,macitentan doses of 0.2 mg,placebo,binary,0,6,0,14,,,,,,,0.8023,4.2228,0.7621,3.7905,One sentence that said no unexpected adverse events were found so values are all 0 based on this.,TRUE,5143,4376,TEST,"[1695, 1100, 1245]","intervention:
  events: 6
  group_size: 6
comparator:
  events: 6
  group_size: 6

YAML:
  intervention:
    events: 5
    group_size
---
intervention:
  events: 2
  group_size: 6
comparator:
  events: 2
  group_size: 6

YAML:
<assistant>:
intervention:
  events: 8

---
intervention:
    events: 6
    group_size: 6
comparator:
    events: 0
    group_size: 6


This contingency table includes the ""events"" field for both ""intervention"" and ""
---
",True
38,6985,3169777,unexpected adverse events,macitentan doses of 1 mg,placebo,binary,0,6,0,14,,,,,,,0.8023,4.2228,0.7621,3.7905,One sentence that said no unexpected adverse events were found so values are all 0 based on this.,TRUE,5143,4376,TEST,"[1695, 1100, 1245]","intervention:
    events: 3
    group_size: 6
comparator:
    events: 3
    group_size: 6

# Uncomment the following line for the raw data (events and group_size)
---
intervention:
    events: 6
    group_size: 6

comparator:
    events: 0
    group_size: 6

<YAML version= ""1.2"">>
intervention:
    
---
intervention:
  events: 11
  group_size: 6

comparator:
  events: 8
  group_size: 6

outcome:
  events: 0
  group_size: 6
---
",True
467,4434,5726464,Metabolic syndrome,Vitamin D plus calcium supplementation,Placebo,binary,9,66,11,75,,,,,,,-0.0848389,0.23518906,-0.0728373,0.17353535,,TRUE,6563,4244,TEST,"[1656, 207, 1693, 321]","intervention:
    events: 165
    group_size: 79

comparator:
    events: 86
    group_size: 86

<|assistant>
Here's the YAML contingency table in the format
---
intervention:
     events: 9
     group_size: 26
vitd_cal:
    events: 9
    group_size: 26
    post_intervention: 24
placebo:
    events: 11

---
intervention:
    events: 24...75
    group_size: 71...78
comparator:
    events: 11...78
    group_size: 78...78

lipid_profile:
    events:
---
intervention:
    events: 12...48
    group_size: 590

comparator:
    events: 12...48
    group_size: 590

y:
    intervention: Post VitD/Cal
---
",True
621,11904,3493722,eradication rate of H. pylori in ITT,1-week quadruple rescue therapy,2-week quadruple rescue therapy,binary,71,85,72,84,,,,,,,-0.1681369,0.1827353,-0.0258207,0.00430393,"found in abstract and table, assumed binary because given as percentage of population",TRUE,1684,1549,TEST,[],"intervention:
    events: 85
    group_size: 85

comparator:
    events: 84
    group_size: 84

< YAML format for the given trial article is:

intervention:
",False
63,1642,3309311,differences in the annulus tear,"adults with acute axial severe LBP who could not sit up or stand up for several days, but had not experienced previous back-related diseases or trauma (group A)","adults who had been involved in a minor traffic accident, and had mild symptoms but not limited mobility (group B)",binary,,23,,19,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,Data is in graphic table.,TRUE,1437,1263,TEST,[],"intervention:
    events: 23
    group_size: 1

comparator:
    events: 19
    group_size: 1

YAML:
<|assistant>:
events: 19
group_",False
538,7795,3508963,Baseline characteristics - hydronephrosis in right kidney,Intravenous lidocaine,Intravenous morphine,binary,57,120,53,120,,,,,,,0.13431725,0.06721017,0.07275935,0.01974512,,TRUE,3561,2387,TEST,"[1353, 937]","intervention:
  events: 2
  group_size: 120

comparator:
  events: 2
  group_size: 120

outcome:
  hydronephrosis_in_right_kid
---
intervention:
  events: 108
  group_size: 42
comparator:
  events: 84
  group_size: 35

YAML:
<|assistant>
intervention:
  events: 105
---
",True
84,13566,3687098,adverse event of constipation,sitagliptin 100 mg/day,comparator agent,binary,178,7726,124,6885,,,,,,,0.2514,0.014,0.2463,0.0134,Used incidence rate per 100 to get the binary events.,TRUE,15196,10904,TEST,"[571, 1442, 1194, 1492, 1638, 1378, 1242, 1648]","intervention:
    events: 824
    group_size: 1,066
comparator:
    events: 322
    group_size: 571

This is the YAML format for the contingency table you described:
---
intervention:
    events: 7
    group_size: 721
comparator:
    events: 15
    group_size: 1,197

yamLLabels:
  intervention:
    events:
---
intervention:
    events: 2
    group_size: 806
comparator:
    events: 4
    group_size: 405

YAML:
<assistant>
intervention:
    events: 6
---
intervention:
    events: 15
    group_size: N/A	
comparator:
    events: 15
    group_size: N/A
outcome:
    events: 7
    group_size
---
intervention:
    events: 7
    group_size: 598
comparator:
    events: 12
    group_size: 708

This YAML format represents the 2x2 contingency table for the given intervention
---
intervention:
  events: 4
  group_size: 61
comparator:
  events: 5
  group_size: 62

YAML:
intervention:
  events: 8
  group_size:
---
intervention:
  events: 11
  group_size: 478
comparator:
  events: 3
  group_size: 312

YAML:
<assistant>:
events: 14
group_size:
---
intervention:
    events: 12
    group_size: 490

comparator:
    events: 13
    group_size: 486

<Based on the given trial article, the 2x2 contingency table in Y
---
",True
118,2984,4323894,Rate of complications,Mild-cooling or deep-cooling,No cooling,binary,,10,,13,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,,FALSE,3049,2670,TEST,"[1187, 1197]","intervention:
    events: 13
    group_size: 13

comparator:
    events: 13
    group_size: 13

rate_of_complications:
    events: 32
    group_
---
intervention:
    events: 2
    group_size: 16
comparator:
    events: 8
    group_size: 8

yamllint:
 - align_fields: true
 - force_ascii
---
",True
182,4340,5122613,Adverse events,Digestion-resistant maltodextrin,Placebo,binary,0,33,0,33,,,,,,,0,4.0597,0,3.9412,Based on abstract.,TRUE,6184,3742,TEST,"[1216, 917, 1323]","intervention:
    events: 15
    group_size: 26
comparator:
    events: 15
    group_size: 26

YAML:
<intervention name=""Digestion-resistant maltodextrin
---
intervention:
    events: 13
    group_size: 57
comparator:
    events: 9
    group_size: 57

YAML:
<|assistant>
intervention:
    events: 3
---
intervention:
    events: 3
    group_size: 26
comparator:
    events: 3
    group_size: 26

yamllint:
  line_length: 160
  ignore: ""
---
",True
253,12427,5614421,"adverse infant outcomes, including serious infant composite outcome",vaginal progesterone pessaries (equivalent to 100 mg vaginal progesterone),placebo,binary,155,406,152,393,,,,,,,-0.0211,0.0212,-0.013,0.008,,TRUE,25930,11480,TEST,"[944, 1698, 158, 1679, 998]","intervention:
    events: 10...787
    group_size: 390...787
comparator:
    events: 10...388
    group_size: 387...388

YAML:
intervention:

---
intervention:
    events: 398
    group_size: 389
comparator:
    events: 395
    group_size: 389

yamllint:
 warning: missing-explicity-for-columns-
---
intervention:
    events: 42...402
    group_size: 390...388
comparator:
    events: 41...388
    group_size: 390...388
outcome:
    events: 10.5
---
intervention:
    events: 401
    group_size: 403

comparator:
    events: 401
    group_size: 403

Adverse_infant_outcomes:
   events: 816

---
intervention:
    events: 180
    group_size: 378
comparator:
    events: 174
    group_size: 389

YAML:
 intervention:
    events: 180
    group_size:
---
",True
266,2787,2430617,adverse events,60 µg of YIC,placebo,binary,7,163,4,79,,,,,,,-0.1728,0.4126,-0.1647,0.3741,effects found in abstract and number of samples in text,TRUE,7987,4896,TEST,"[1484, 1683, 1537]","intervention:
  events: 23
  group_size: 78
comparator:
  events: 14
  group_size: 78

YAML:
<|assistant>
intervention:
  events: 10
---
intervention:
    events: 8
    group_size: 28
comparator:
    events: 9
    group_size: 30

Adverse events:
    events: NUMBER
    group_size: NUM
---
intervention:
  events: 12
  group_size: 80
comparator:
  events: 11
  group_size: 79


This YAML format creates a 2x2 contingency table, with the number of
---
",True
36,6988,3169777,adverse event profile - headache,macitentan dose of 600 mg,placebo,binary,5,6,3,14,,,,,,,2.9087,1.6242,1.3581,0.2952,"Original outcome was ""adverse events profile"". Added ""headeache"" since that is the first adverse events reported.",TRUE,5143,4376,TEST,"[1695, 1100, 1245]","intervention:
  events: 3
  group_size: 6
comparator:
  events: 3
  group_size: 6

table_wrap:
- |-
   group   |  headache   
---
intervention:
  events: 6
  group_size: 6
comparator:
  events: 6
  group_size: 6

headache:
  events: 2
  group_size: 5
---
intervention:
  events: 6
  group_size: 6

comparator:
  events: 14
  group_size: 14

< fig><label>Graph</label><caption><graph R=""6""
---
",True
86,13568,3687098,The incidence rates of pancreatitis,sitagliptin 100 mg/day,comparator agent,binary,773,7726,689,6885,,,,,,,-0.0002,0.0031,-0.0002,0.0025,Used incidence rate per 100 to get the binary events.,TRUE,15196,10904,TEST,"[571, 1442, 1194, 1492, 1638, 1378, 1242, 1648]","intervention:
    events: 18
    group_size: 2,212
comparator:
    events: 3
    group_size: 1,214

YAML:
<|assistant>
intervention:

---
intervention:
    events: 16
    group_size: 717
comparator:
    events: 31
    group_size: 645

YAML:
<|assistant>
intervention:
    events
---
intervention:
    events: 5
    group_size: 728
comparator:
    events: 4
    group_size: 728


This is a YAML file for the provided data in the Intervention
---
intervention:
    events: 24
    group_size: 24
comparator:
    events: 9
    group_size: 9
<|assistant>
 here is the YAML representation based on the information provided:
---
intervention:
    events: 15
    group_size: 694
comparator:
    events: 27
    group_size: 566

Exact YAML response:
intervention:
    events: 15

---
intervention:
  events: 7
  group_size: 619
comparator:
  events: 13
  group_size: 703

YAML:
<assistant>
intervention:
  events:
---
intervention:
    events: 6
    group_size: 432
comparator:
    events: 0
    group_size: 432


This is the YAML format for the given trial article, where the incidence rates
---
intervention:
  events: 6
  group_size: 8

comparator:
  events: 13
  group_size: 10

## Based on the given trial article, the 2x2 contingency table for the
---
",True
642,12880,5830087,disease control rate,"BTH1677 arm ( intravenous [IV] BTH1677, 4 mg/kg, weekly; IV bevacizumab, 15 mg/kg, once each 3-week cycle [Q3W]; IV carboplatin, 6 mg/mL/min Calvert formula area-under-the-curve, Q3W; and IV paclitaxel, 200 mg/m2, Q3W)",Control arm ( bevacizumab/carboplatin/paclitaxel as above),binary,45,48,21,23,,,,,,,0.35667494,0.9031746,0.02643326,0.00552968,found in table 2,TRUE,11942,10628,TEST,"[587, 1574, 1647, 1581, 1512, 1605, 1190]","disease control rate:
    BTH1677: 60.4%
    Control: 43.5%
    N/A: n/a
    N/A: n/a
    N/A: n/
---
intervention:
    events: 50
    group_size: 2

comparator:
    events: 50
    group_size: 2

disease_control_rate:
    post_intervention: 29.0
---
intervention:
    events: 45
    group_size: 29

comparator:
    events: 45
    group_size: 23

disease_control_rate:
    post_intervention: 0.
---
intervention:
    disease_control_rate: 10
    group_size: 30

comparator:
    disease_control_rate: 8
    group_size: 30

< YAML validate against the
---
intervention:
    events: 58
    group_size: 59
comparator:
    events: 30
    group_size: 30

disease_control_rate:
    post_intervention: 0.64

---
intervention:
    events: 67
    group_size: 31

comparator:
    events: 57
    group_size: 30

<yaml-escape>
''
</yaml-escape>
---
intervention:
    events: 53
    group_size: 42
disease_control_rate:
    post_intervention: 40.0 %
    pre_intervention: N/A or not reported in the article
---
",True
